Target Gene/Pathway Pathway / Gene

  

Search results

No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related 		KEGG GENES KEGG DRUG DrugBank 指定難病告示番号
1 Acute myeloid leukemia 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
2 Acute myeloid leukemia 💬
 4件: BRAF, FLT3, KIT, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
3 Acute myeloid leukemia 💬
 4件: BRAF, FLT3, KIT, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
4 Acute myeloid leukemia 💬
 3件: CSF1R, FLT3, KIT 💬 D11270 💬 Pexidartinib 1件: 34 💬
5 Acute myeloid leukemia 💬
 2件: FLT3, KIT 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
6 Acute myeloid leukemia 💬
 2件: FLT3, KIT 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
7 Acute myeloid leukemia 💬
 1件: KIT 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
8 Acute myeloid leukemia 💬
 1件: KIT 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
9 Acute myeloid leukemia 💬
 1件: KIT 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
10 Acute myeloid leukemia 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
11 Acute myeloid leukemia 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
12 Acute myeloid leukemia 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
13 Acute myeloid leukemia 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
14 Acute myeloid leukemia 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
15 Acute myeloid leukemia 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
16 Adherens junction 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
17 Adherens junction 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
18 Adherens junction 💬
 2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
19 Adherens junction 💬
 2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
20 Adherens junction 💬
 1件: MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
21 Adipocytokine signaling pathway 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
22 Adipocytokine signaling pathway 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
23 Adipocytokine signaling pathway 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
24 Adipocytokine signaling pathway 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
25 Adipocytokine signaling pathway 💬
 1件: TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
26 Adipocytokine signaling pathway 💬
 1件: TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
27 Adrenergic signaling in cardiomyocytes 💬
 1件: SCN5A 💬 D00354 💬 Lamotrigine 5件: 13, 34, 38, 114, 144 💬
28 Adrenergic signaling in cardiomyocytes 💬
 1件: SCN5A 💬 D00358 💬 Lidocaine 13件:  6 , 13, 34, 46, 51, 70, 84, 86, 107, 168, 226, 231, 256 💬
29 Adrenergic signaling in cardiomyocytes 💬
 1件: SCN5A 💬 D02086 💬 Lidocaine 13件:  6 , 13, 34, 46, 51, 70, 84, 86, 107, 168, 226, 231, 256 💬
30 Adrenergic signaling in cardiomyocytes 💬
 1件: SCN5A 💬 D08127 💬 Lidocaine 13件:  6 , 13, 34, 46, 51, 70, 84, 86, 107, 168, 226, 231, 256 💬
31 African trypanosomiasis 💬
 4件: IL10, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
32 African trypanosomiasis 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
33 African trypanosomiasis 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
34 AGE-RAGE signaling pathway in diabetic complications 💬
 5件: CCL2, IL1A, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
35 AGE-RAGE signaling pathway in diabetic complications 💬
 1件: CDK4 💬 D10688 💬 Abemaciclib 1件: 34 💬
36 AGE-RAGE signaling pathway in diabetic complications 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
37 AGE-RAGE signaling pathway in diabetic complications 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
38 AGE-RAGE signaling pathway in diabetic complications 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
39 AGE-RAGE signaling pathway in diabetic complications 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
40 Alanine, aspartate and glutamate metabolism 💬
 4件: ABAT, ALDH5A1, GAD1, GAD2 💬 D00399 💬 Valproic acid 17件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 127, 222, 233, 256, 331 💬
41 Alcoholic liver disease 💬
 3件: IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
42 Alcoholic liver disease 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
43 Alcoholic liver disease 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
44 Alcoholism 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
45 Alcoholism 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
46 Alcoholism 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
47 Alcoholism 💬
 1件: MAP2K1 💬 D10604 💬 Binimetinib 1件: 34 💬
48 Alcoholism 💬
 1件: MAP2K1 💬 D09666 💬 Selumetinib 1件: 34 💬
49 Alcoholism 💬
 1件: MAP2K1 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
50 Alcoholism 💬
 1件: SLC6A3 💬 D01296 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
51 Alcoholism 💬
 1件: SLC6A3 💬 D04999 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
52 Aldosterone synthesis and secretion 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 D00399 💬 Valproic acid 17件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 127, 222, 233, 256, 331 💬
53 Allograft rejection 💬
 2件: IL10, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
54 Allograft rejection 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
55 Allograft rejection 💬
 1件: TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
56 Alzheimer disease 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
57 Alzheimer disease 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
58 Alzheimer disease 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
59 Alzheimer disease 💬
 1件: CSF1 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
60 Alzheimer disease 💬
 1件: CSF1 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
61 Alzheimer disease 💬
 4件: IL1A, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
62 Alzheimer disease 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
63 Alzheimer disease 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
64 Alzheimer disease 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
65 Alzheimer disease 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
66 Alzheimer disease 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
67 Alzheimer disease 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
68 Alzheimer disease 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
69 Alzheimer disease 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271, 300, 337 💬
70 Alzheimer disease 💬
 1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
71 Alzheimer disease 💬
 1件: PTGS2 💬 D00567 💬 Celecoxib 10件:  2 ,  3 , 34, 46, 70, 89, 107, 161, 171, 271 💬
72 Alzheimer disease 💬
 1件: PTGS2 💬 D00903 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
73 Alzheimer disease 💬
 1件: PTGS2 💬 D00904 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
74 Alzheimer disease 💬
 1件: PTGS2 💬 D07816 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
75 Alzheimer disease 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
76 Alzheimer disease 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D01068 💬 Vinblastine 2件: 34, 65 💬
77 Alzheimer disease 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08675 💬 Vinblastine 2件: 34, 65 💬
78 Alzheimer disease 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D02197 💬 Vincristine 4件: 26, 34, 65, 331 💬
79 Alzheimer disease 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08679 💬 Vincristine 4件: 26, 34, 65, 331 💬
80 Amoebiasis 💬
 4件: IL10, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
81 Amoebiasis 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
82 Amoebiasis 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
83 Amphetamine addiction 💬
 1件: SLC6A3 💬 D01296 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
84 Amphetamine addiction 💬
 1件: SLC6A3 💬 D04999 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
85 AMPK signaling pathway 💬
 1件: HMGCR 💬 D00359 💬 Lovastatin 11件:  6 , 34, 46, 79, 156, 160, 195, 206, 263, 280, 310 💬
86 AMPK signaling pathway 💬
 1件: HMGCR 💬 D00434 💬 Simvastatin 21件:  6 , 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬
87 AMPK signaling pathway 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
88 AMPK signaling pathway 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
89 AMPK signaling pathway 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
90 Amyotrophic lateral sclerosis 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
91 Amyotrophic lateral sclerosis 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
92 Amyotrophic lateral sclerosis 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
93 Amyotrophic lateral sclerosis 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
94 Amyotrophic lateral sclerosis 💬
 1件: TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
95 Amyotrophic lateral sclerosis 💬
 1件: TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
96 Amyotrophic lateral sclerosis 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D01068 💬 Vinblastine 2件: 34, 65 💬
97 Amyotrophic lateral sclerosis 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08675 💬 Vinblastine 2件: 34, 65 💬
98 Amyotrophic lateral sclerosis 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D02197 💬 Vincristine 4件: 26, 34, 65, 331 💬
99 Amyotrophic lateral sclerosis 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08679 💬 Vincristine 4件: 26, 34, 65, 331 💬
100 Antifolate resistance 💬
 2件: DHFR, DHFR2 💬 D00142 💬 Methotrexate 38件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 283, 284, 285, 286, 326, 331 💬
101 Antifolate resistance 💬
 2件: DHFR, DHFR2 💬 D02115 💬 Methotrexate 38件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 283, 284, 285, 286, 326, 331 💬
102 Antifolate resistance 💬
 3件: IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
103 Antifolate resistance 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
104 Antifolate resistance 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
105 Antigen processing and presentation 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
106 Antigen processing and presentation 💬
 1件: TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
107 Antigen processing and presentation 💬
 1件: TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
108 Apelin signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
109 Apelin signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
110 Apelin signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
111 Apelin signaling pathway 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
112 Apelin signaling pathway 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
113 Apelin signaling pathway 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
114 Apelin signaling pathway 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
115 Apelin signaling pathway 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
116 Apoptosis 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
117 Apoptosis 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
118 Apoptosis 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
119 Apoptosis 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
120 Apoptosis 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
121 Apoptosis 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
122 Apoptosis 💬
 1件: TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
123 Apoptosis 💬
 1件: TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
124 Arachidonic acid metabolism 💬
 2件: PTGS1, PTGS2 💬 D00217 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271, 300, 337 💬
125 Arachidonic acid metabolism 💬
 2件: PTGS1, PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
126 Arachidonic acid metabolism 💬
 2件: PTGS1, PTGS2 💬 D00903 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
127 Arachidonic acid metabolism 💬
 2件: PTGS1, PTGS2 💬 D00904 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
128 Arachidonic acid metabolism 💬
 2件: PTGS1, PTGS2 💬 D07816 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
129 Arachidonic acid metabolism 💬
 1件: PTGS2 💬 D00567 💬 Celecoxib 10件:  2 ,  3 , 34, 46, 70, 89, 107, 161, 171, 271 💬
130 Asthma 💬
 2件: IL10, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
131 Asthma 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
132 Asthma 💬
 1件: TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
133 Autoimmune thyroid disease 💬
 1件: IL10 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
134 Autophagy - animal 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
135 Autophagy - animal 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
136 Autophagy - animal 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
137 Autophagy - animal 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
138 Autophagy - animal 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
139 Autophagy - animal 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
140 Autophagy - animal 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
141 Autophagy - animal 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
142 Autophagy - other 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
143 Autophagy - other 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
144 Autophagy - other 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
145 Axon guidance 💬
 1件: ABL1 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
146 Axon guidance 💬
 1件: ABL1 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
147 Axon guidance 💬
 1件: ABL1 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
148 Axon guidance 💬
 1件: BMPR2 💬 D03779 💬 Dibotermin alfa 1件: 34 💬
149 Axon guidance 💬
 1件: MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
150 Axon guidance 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
151 Axon guidance 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
152 B cell receptor signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
153 B cell receptor signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
154 B cell receptor signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
155 B cell receptor signaling pathway 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
156 B cell receptor signaling pathway 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
157 Bacterial invasion of epithelial cells 💬
 1件: MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
158 beta-Alanine metabolism 💬
 3件: ABAT, GAD1, GAD2 💬 D00399 💬 Valproic acid 17件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 127, 222, 233, 256, 331 💬
159 Bile secretion 💬
 1件: HMGCR 💬 D00359 💬 Lovastatin 11件:  6 , 34, 46, 79, 156, 160, 195, 206, 263, 280, 310 💬
160 Bile secretion 💬
 1件: HMGCR 💬 D00434 💬 Simvastatin 21件:  6 , 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬
161 Biosynthesis of cofactors 💬
 2件: DHFR, DHFR2 💬 D00142 💬 Methotrexate 38件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 283, 284, 285, 286, 326, 331 💬
162 Biosynthesis of cofactors 💬
 2件: DHFR, DHFR2 💬 D02115 💬 Methotrexate 38件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 283, 284, 285, 286, 326, 331 💬
163 Bladder cancer 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
164 Bladder cancer 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
165 Bladder cancer 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
166 Bladder cancer 💬
 1件: CDK4 💬 D10688 💬 Abemaciclib 1件: 34 💬
167 Bladder cancer 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
168 Bladder cancer 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
169 Bladder cancer 💬
 2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
170 Bladder cancer 💬
 2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
171 Bladder cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
172 Bladder cancer 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
173 Bladder cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
174 Bladder cancer 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
175 Bladder cancer 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
176 Breast cancer 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
177 Breast cancer 💬
 4件: BRAF, FLT4, KIT, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
178 Breast cancer 💬
 4件: BRAF, FLT4, KIT, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
179 Breast cancer 💬
 2件: CDK4, CDK6 💬 D10688 💬 Abemaciclib 1件: 34 💬
180 Breast cancer 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
181 Breast cancer 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
182 Breast cancer 💬
 2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
183 Breast cancer 💬
 2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
184 Breast cancer 💬
 1件: FLT4 💬 D03218 💬 Axitinib 1件: 34 💬
185 Breast cancer 💬
 1件: FLT4 💬 D08881 💬 Cediranib 1件: 34 💬
186 Breast cancer 💬
 2件: FLT4, KIT 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
187 Breast cancer 💬
 2件: FLT4, KIT 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
188 Breast cancer 💬
 1件: KIT 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
189 Breast cancer 💬
 1件: KIT 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
190 Breast cancer 💬
 1件: KIT 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
191 Breast cancer 💬
 1件: KIT 💬 D11270 💬 Pexidartinib 1件: 34 💬
192 Breast cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
193 Breast cancer 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
194 Breast cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
195 Breast cancer 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
196 Breast cancer 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
197 Breast cancer 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
198 Butanoate metabolism 💬
 4件: ABAT, ALDH5A1, GAD1, GAD2 💬 D00399 💬 Valproic acid 17件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 127, 222, 233, 256, 331 💬
199 C-type lectin receptor signaling pathway 💬
 4件: IL10, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
200 C-type lectin receptor signaling pathway 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
201 C-type lectin receptor signaling pathway 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271, 300, 337 💬
202 C-type lectin receptor signaling pathway 💬
 1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
203 C-type lectin receptor signaling pathway 💬
 1件: PTGS2 💬 D00567 💬 Celecoxib 10件:  2 ,  3 , 34, 46, 70, 89, 107, 161, 171, 271 💬
204 C-type lectin receptor signaling pathway 💬
 1件: PTGS2 💬 D00903 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
205 C-type lectin receptor signaling pathway 💬
 1件: PTGS2 💬 D00904 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
206 C-type lectin receptor signaling pathway 💬
 1件: PTGS2 💬 D07816 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
207 C-type lectin receptor signaling pathway 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
208 C-type lectin receptor signaling pathway 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
209 C-type lectin receptor signaling pathway 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
210 Calcium signaling pathway 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 D00399 💬 Valproic acid 17件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 127, 222, 233, 256, 331 💬
211 Calcium signaling pathway 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
212 Calcium signaling pathway 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
213 Calcium signaling pathway 💬
 2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
214 Calcium signaling pathway 💬
 2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
215 Calcium signaling pathway 💬
 3件: FLT1, FLT4, KDR 💬 D03218 💬 Axitinib 1件: 34 💬
216 Calcium signaling pathway 💬
 3件: FLT1, FLT4, KDR 💬 D08881 💬 Cediranib 1件: 34 💬
217 Calcium signaling pathway 💬
 6件: FLT1, FLT4, KDR, PDGFRA, PDGFRB, RET 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
218 Calcium signaling pathway 💬
 6件: FLT1, FLT4, KDR, PDGFRA, PDGFRB, RET 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
219 Calcium signaling pathway 💬
 4件: FLT4, KDR, PDGFRB, RET 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
220 Calcium signaling pathway 💬
 4件: FLT4, KDR, PDGFRB, RET 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
221 Calcium signaling pathway 💬
 2件: KDR, MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
222 Calcium signaling pathway 💬
 1件: PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
223 Calcium signaling pathway 💬
 1件: PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
224 Calcium signaling pathway 💬
 2件: PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
225 Calcium signaling pathway 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
226 Calcium signaling pathway 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
227 cAMP signaling pathway 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
228 cAMP signaling pathway 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
229 cAMP signaling pathway 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
230 cAMP signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
231 cAMP signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
232 cAMP signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
233 Cell cycle 💬
 1件: ABL1 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
234 Cell cycle 💬
 1件: ABL1 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
235 Cell cycle 💬
 1件: ABL1 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
236 Cell cycle 💬
 2件: CDK4, CDK6 💬 D10688 💬 Abemaciclib 1件: 34 💬
237 Cellular senescence 💬
 2件: CDK4, CDK6 💬 D10688 💬 Abemaciclib 1件: 34 💬
238 Cellular senescence 💬
 2件: IL1A, IL6 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
239 Cellular senescence 💬
 1件: IL6 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
240 Cellular senescence 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
241 Cellular senescence 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
242 Cellular senescence 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
243 Cellular senescence 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
244 Cellular senescence 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
245 Cellular senescence 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
246 Cellular senescence 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
247 Cellular senescence 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
248 Central carbon metabolism in cancer 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
249 Central carbon metabolism in cancer 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
250 Central carbon metabolism in cancer 💬
 2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
251 Central carbon metabolism in cancer 💬
 2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
252 Central carbon metabolism in cancer 💬
 2件: FLT3, KIT 💬 D11270 💬 Pexidartinib 1件: 34 💬
253 Central carbon metabolism in cancer 💬
 5件: FLT3, KIT, PDGFRA, PDGFRB, RET 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
254 Central carbon metabolism in cancer 💬
 5件: FLT3, KIT, PDGFRA, PDGFRB, RET 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
255 Central carbon metabolism in cancer 💬
 5件: FLT3, KIT, PDGFRB, RAF1, RET 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
256 Central carbon metabolism in cancer 💬
 5件: FLT3, KIT, PDGFRB, RAF1, RET 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
257 Central carbon metabolism in cancer 💬
 2件: KIT, PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
258 Central carbon metabolism in cancer 💬
 2件: KIT, PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
259 Central carbon metabolism in cancer 💬
 3件: KIT, PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
260 Central carbon metabolism in cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
261 Central carbon metabolism in cancer 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
262 Central carbon metabolism in cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
263 Central carbon metabolism in cancer 💬
 1件: MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
264 Central carbon metabolism in cancer 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
265 Central carbon metabolism in cancer 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
266 Central carbon metabolism in cancer 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
267 cGMP-PKG signaling pathway 💬
 3件: ADRA2A, ADRA2B, ADRA2C 💬 D00514 💬 Dexmedetomidine 13件:  2 ,  4 ,  6 , 21, 34, 46, 70, 107, 113, 212, 215, 226, 280 💬
268 cGMP-PKG signaling pathway 💬
 3件: ADRA2A, ADRA2B, ADRA2C 💬 D01205 💬 Dexmedetomidine 13件:  2 ,  4 ,  6 , 21, 34, 46, 70, 107, 113, 212, 215, 226, 280 💬
269 cGMP-PKG signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
270 cGMP-PKG signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
271 cGMP-PKG signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
272 cGMP-PKG signaling pathway 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
273 cGMP-PKG signaling pathway 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
274 Chagas disease 💬
 5件: CCL2, IL10, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
275 Chagas disease 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
276 Chagas disease 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
277 Chemical carcinogenesis - DNA adducts 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271, 300, 337 💬
278 Chemical carcinogenesis - DNA adducts 💬
 1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
279 Chemical carcinogenesis - DNA adducts 💬
 1件: PTGS2 💬 D00567 💬 Celecoxib 10件:  2 ,  3 , 34, 46, 70, 89, 107, 161, 171, 271 💬
280 Chemical carcinogenesis - DNA adducts 💬
 1件: PTGS2 💬 D00903 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
281 Chemical carcinogenesis - DNA adducts 💬
 1件: PTGS2 💬 D00904 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
282 Chemical carcinogenesis - DNA adducts 💬
 1件: PTGS2 💬 D07816 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
283 Chemical carcinogenesis - reactive oxygen species 💬
 1件: ABL1 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
284 Chemical carcinogenesis - reactive oxygen species 💬
 1件: ABL1 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
285 Chemical carcinogenesis - reactive oxygen species 💬
 1件: ABL1 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
286 Chemical carcinogenesis - reactive oxygen species 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
287 Chemical carcinogenesis - reactive oxygen species 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
288 Chemical carcinogenesis - reactive oxygen species 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
289 Chemical carcinogenesis - reactive oxygen species 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
290 Chemical carcinogenesis - reactive oxygen species 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
291 Chemical carcinogenesis - reactive oxygen species 💬
 1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
292 Chemical carcinogenesis - reactive oxygen species 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
293 Chemical carcinogenesis - reactive oxygen species 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
294 Chemical carcinogenesis - reactive oxygen species 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
295 Chemical carcinogenesis - reactive oxygen species 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
296 Chemical carcinogenesis - reactive oxygen species 💬
 1件: MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
297 Chemical carcinogenesis - reactive oxygen species 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
298 Chemical carcinogenesis - reactive oxygen species 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
299 Chemical carcinogenesis - receptor activation 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
300 Chemical carcinogenesis - receptor activation 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
301 Chemical carcinogenesis - receptor activation 💬
 1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
302 Chemical carcinogenesis - receptor activation 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
303 Chemical carcinogenesis - receptor activation 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
304 Chemical carcinogenesis - receptor activation 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
305 Chemical carcinogenesis - receptor activation 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
306 Chemical carcinogenesis - receptor activation 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
307 Chemical carcinogenesis - receptor activation 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
308 Chemical carcinogenesis - receptor activation 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
309 Chemical carcinogenesis - receptor activation 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
310 Chemical carcinogenesis - receptor activation 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
311 Chemical carcinogenesis - receptor activation 💬
 1件: VDR 💬 D00188 💬 Cholecalciferol 25件:  6 , 13, 19, 20, 28, 34, 46, 49, 51, 53, 56, 60, 65, 75, 84, 85, 96, 97, 98, 162, 202, 228, 271, 298, 299 💬
312 Chemical carcinogenesis - receptor activation 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
313 Chemical carcinogenesis - receptor activation 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
314 Chemokine signaling pathway 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
315 Chemokine signaling pathway 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
316 Chemokine signaling pathway 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
317 Chemokine signaling pathway 💬
 1件: CCL2 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
318 Chemokine signaling pathway 💬
 1件: MAP2K1 💬 D10604 💬 Binimetinib 1件: 34 💬
319 Chemokine signaling pathway 💬
 1件: MAP2K1 💬 D09666 💬 Selumetinib 1件: 34 💬
320 Chemokine signaling pathway 💬
 1件: MAP2K1 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
321 Choline metabolism in cancer 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
322 Choline metabolism in cancer 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
323 Choline metabolism in cancer 💬
 1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
324 Choline metabolism in cancer 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
325 Choline metabolism in cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
326 Choline metabolism in cancer 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
327 Choline metabolism in cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
328 Choline metabolism in cancer 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
329 Choline metabolism in cancer 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
330 Choline metabolism in cancer 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
331 Choline metabolism in cancer 💬
 1件: PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
332 Choline metabolism in cancer 💬
 1件: PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
333 Choline metabolism in cancer 💬
 2件: PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
334 Choline metabolism in cancer 💬
 2件: PDGFRA, PDGFRB 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
335 Choline metabolism in cancer 💬
 2件: PDGFRA, PDGFRB 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
336 Choline metabolism in cancer 💬
 2件: PDGFRB, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
337 Choline metabolism in cancer 💬
 2件: PDGFRB, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
338 Cholinergic synapse 💬
 1件: MAP2K1 💬 D10604 💬 Binimetinib 1件: 34 💬
339 Cholinergic synapse 💬
 1件: MAP2K1 💬 D09666 💬 Selumetinib 1件: 34 💬
340 Cholinergic synapse 💬
 1件: MAP2K1 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
341 Chronic myeloid leukemia 💬
 1件: ABL1 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
342 Chronic myeloid leukemia 💬
 1件: ABL1 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
343 Chronic myeloid leukemia 💬
 1件: ABL1 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
344 Chronic myeloid leukemia 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
345 Chronic myeloid leukemia 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
346 Chronic myeloid leukemia 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
347 Chronic myeloid leukemia 💬
 2件: CDK4, CDK6 💬 D10688 💬 Abemaciclib 1件: 34 💬
348 Chronic myeloid leukemia 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
349 Chronic myeloid leukemia 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
350 Chronic myeloid leukemia 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
351 Circadian entrainment 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 D00399 💬 Valproic acid 17件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 127, 222, 233, 256, 331 💬
352 Cocaine addiction 💬
 1件: SLC6A3 💬 D01296 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
353 Cocaine addiction 💬
 1件: SLC6A3 💬 D04999 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
354 Colorectal cancer 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
355 Colorectal cancer 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
356 Colorectal cancer 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
357 Colorectal cancer 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
358 Colorectal cancer 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
359 Colorectal cancer 💬
 1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
360 Colorectal cancer 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
361 Colorectal cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
362 Colorectal cancer 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
363 Colorectal cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
364 Colorectal cancer 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
365 Colorectal cancer 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
366 Colorectal cancer 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
367 Coronavirus disease - COVID-19 💬
 4件: CCL2, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
368 Coronavirus disease - COVID-19 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
369 Coronavirus disease - COVID-19 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
370 Coronavirus disease - COVID-19 💬
 1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
371 Coronavirus disease - COVID-19 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
372 Coronavirus disease - COVID-19 💬
 2件: IFNAR1, IFNAR2 💬 D02745 💬 Interferon alfa-2b 2件: 25, 34 💬
373 Coronavirus disease - COVID-19 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
374 Coronavirus disease - COVID-19 💬
 1件: TLR7 💬 D02500 💬 Imiquimod 2件: 34, 51 💬
375 Coronavirus disease - COVID-19 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
376 Cortisol synthesis and secretion 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 D00399 💬 Valproic acid 17件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 127, 222, 233, 256, 331 💬
377 Cushing syndrome 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
378 Cushing syndrome 💬
 1件: BRAF 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
379 Cushing syndrome 💬
 1件: BRAF 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
380 Cushing syndrome 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 D00399 💬 Valproic acid 17件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 127, 222, 233, 256, 331 💬
381 Cushing syndrome 💬
 2件: CDK4, CDK6 💬 D10688 💬 Abemaciclib 1件: 34 💬
382 Cushing syndrome 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
383 Cushing syndrome 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
384 Cushing syndrome 💬
 1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
385 Cushing syndrome 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
386 Cushing syndrome 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
387 Cushing syndrome 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
388 Cushing syndrome 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
389 Cytokine-cytokine receptor interaction 💬
 1件: BMPR2 💬 D03779 💬 Dibotermin alfa 1件: 34 💬
390 Cytokine-cytokine receptor interaction 💬
 6件: CCL2, IL10, IL1A, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
391 Cytokine-cytokine receptor interaction 💬
 1件: CSF1 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
392 Cytokine-cytokine receptor interaction 💬
 1件: CSF1 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
393 Cytokine-cytokine receptor interaction 💬
 1件: CSF1R 💬 D11270 💬 Pexidartinib 1件: 34 💬
394 Cytokine-cytokine receptor interaction 💬
 1件: CSF3R 💬 D03235 💬 Filgrastim 34件:  2 ,  6 , 11, 13, 16, 25, 26, 28, 34, 35, 36, 38, 40, 41, 42, 45, 46, 47, 49, 51, 57, 60, 62, 65, 85, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
395 Cytokine-cytokine receptor interaction 💬
 2件: IFNAR1, IFNAR2 💬 D02745 💬 Interferon alfa-2b 2件: 25, 34 💬
396 Cytokine-cytokine receptor interaction 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
397 Cytokine-cytokine receptor interaction 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
398 Cytosolic DNA-sensing pathway 💬
 2件: IL1B, IL6 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
399 Cytosolic DNA-sensing pathway 💬
 1件: IL6 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
400 Diabetic cardiomyopathy 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
401 Diabetic cardiomyopathy 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
402 Diabetic cardiomyopathy 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
403 Dilated cardiomyopathy 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
404 Dilated cardiomyopathy 💬
 1件: TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
405 Dilated cardiomyopathy 💬
 1件: TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
406 Dopaminergic synapse 💬
 1件: SCN1A 💬 D00354 💬 Lamotrigine 5件: 13, 34, 38, 114, 144 💬
407 Dopaminergic synapse 💬
 1件: SCN1A 💬 D00358 💬 Lidocaine 13件:  6 , 13, 34, 46, 51, 70, 84, 86, 107, 168, 226, 231, 256 💬
408 Dopaminergic synapse 💬
 1件: SCN1A 💬 D02086 💬 Lidocaine 13件:  6 , 13, 34, 46, 51, 70, 84, 86, 107, 168, 226, 231, 256 💬
409 Dopaminergic synapse 💬
 1件: SCN1A 💬 D08127 💬 Lidocaine 13件:  6 , 13, 34, 46, 51, 70, 84, 86, 107, 168, 226, 231, 256 💬
410 Dopaminergic synapse 💬
 1件: SLC6A3 💬 D01296 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
411 Dopaminergic synapse 💬
 1件: SLC6A3 💬 D04999 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
412 EGFR tyrosine kinase inhibitor resistance 💬
 3件: AXL, KDR, MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
413 EGFR tyrosine kinase inhibitor resistance 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
414 EGFR tyrosine kinase inhibitor resistance 💬
 4件: BRAF, KDR, PDGFRB, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
415 EGFR tyrosine kinase inhibitor resistance 💬
 4件: BRAF, KDR, PDGFRB, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
416 EGFR tyrosine kinase inhibitor resistance 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
417 EGFR tyrosine kinase inhibitor resistance 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
418 EGFR tyrosine kinase inhibitor resistance 💬
 2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
419 EGFR tyrosine kinase inhibitor resistance 💬
 2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
420 EGFR tyrosine kinase inhibitor resistance 💬
 1件: IL6 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
421 EGFR tyrosine kinase inhibitor resistance 💬
 1件: IL6 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
422 EGFR tyrosine kinase inhibitor resistance 💬
 1件: KDR 💬 D03218 💬 Axitinib 1件: 34 💬
423 EGFR tyrosine kinase inhibitor resistance 💬
 1件: KDR 💬 D08881 💬 Cediranib 1件: 34 💬
424 EGFR tyrosine kinase inhibitor resistance 💬
 3件: KDR, PDGFRA, PDGFRB 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
425 EGFR tyrosine kinase inhibitor resistance 💬
 3件: KDR, PDGFRA, PDGFRB 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
426 EGFR tyrosine kinase inhibitor resistance 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
427 EGFR tyrosine kinase inhibitor resistance 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
428 EGFR tyrosine kinase inhibitor resistance 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
429 EGFR tyrosine kinase inhibitor resistance 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
430 EGFR tyrosine kinase inhibitor resistance 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
431 EGFR tyrosine kinase inhibitor resistance 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
432 EGFR tyrosine kinase inhibitor resistance 💬
 1件: PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
433 EGFR tyrosine kinase inhibitor resistance 💬
 1件: PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
434 EGFR tyrosine kinase inhibitor resistance 💬
 2件: PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
435 EGFR tyrosine kinase inhibitor resistance 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
436 EGFR tyrosine kinase inhibitor resistance 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
437 Endocrine and other factor-regulated calcium reabsorption 💬
 1件: VDR 💬 D00188 💬 Cholecalciferol 25件:  6 , 13, 19, 20, 28, 34, 46, 49, 51, 53, 56, 60, 65, 75, 84, 85, 96, 97, 98, 162, 202, 228, 271, 298, 299 💬
438 Endocrine resistance 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
439 Endocrine resistance 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
440 Endocrine resistance 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
441 Endocrine resistance 💬
 1件: CDK4 💬 D10688 💬 Abemaciclib 1件: 34 💬
442 Endocrine resistance 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
443 Endocrine resistance 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
444 Endocrine resistance 💬
 2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
445 Endocrine resistance 💬
 2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
446 Endocrine resistance 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
447 Endocrine resistance 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
448 Endocrine resistance 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
449 Endocrine resistance 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
450 Endocrine resistance 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
451 Endocrine resistance 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
452 Endocytosis 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
453 Endocytosis 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
454 Endocytosis 💬
 1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
455 Endocytosis 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
456 Endocytosis 💬
 1件: PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
457 Endocytosis 💬
 1件: PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
458 Endocytosis 💬
 1件: PDGFRA 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
459 Endocytosis 💬
 1件: PDGFRA 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
460 Endocytosis 💬
 1件: PDGFRA 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
461 Endometrial cancer 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
462 Endometrial cancer 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
463 Endometrial cancer 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
464 Endometrial cancer 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
465 Endometrial cancer 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
466 Endometrial cancer 💬
 2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
467 Endometrial cancer 💬
 2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
468 Endometrial cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
469 Endometrial cancer 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
470 Endometrial cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
471 Epithelial cell signaling in Helicobacter pylori infection 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
472 Epithelial cell signaling in Helicobacter pylori infection 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
473 Epithelial cell signaling in Helicobacter pylori infection 💬
 1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
474 Epithelial cell signaling in Helicobacter pylori infection 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
475 Epithelial cell signaling in Helicobacter pylori infection 💬
 1件: MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
476 Epstein-Barr virus infection 💬
 2件: CDK4, CDK6 💬 D10688 💬 Abemaciclib 1件: 34 💬
477 Epstein-Barr virus infection 💬
 2件: IFNAR1, IFNAR2 💬 D02745 💬 Interferon alfa-2b 2件: 25, 34 💬
478 Epstein-Barr virus infection 💬
 2件: IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
479 Epstein-Barr virus infection 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
480 Epstein-Barr virus infection 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
481 ErbB signaling pathway 💬
 1件: ABL1 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
482 ErbB signaling pathway 💬
 1件: ABL1 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
483 ErbB signaling pathway 💬
 1件: ABL1 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
484 ErbB signaling pathway 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
485 ErbB signaling pathway 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
486 ErbB signaling pathway 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
487 ErbB signaling pathway 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
488 ErbB signaling pathway 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
489 ErbB signaling pathway 💬
 2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
490 ErbB signaling pathway 💬
 2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
491 ErbB signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
492 ErbB signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
493 ErbB signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
494 ErbB signaling pathway 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
495 ErbB signaling pathway 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
496 ErbB signaling pathway 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
497 Estrogen signaling pathway 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
498 Estrogen signaling pathway 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
499 Estrogen signaling pathway 💬
 1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
500 Estrogen signaling pathway 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
501 Estrogen signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
502 Estrogen signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
503 Estrogen signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
504 Estrogen signaling pathway 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
505 Estrogen signaling pathway 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
506 Fc epsilon RI signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
507 Fc epsilon RI signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
508 Fc epsilon RI signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
509 Fc epsilon RI signaling pathway 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
510 Fc epsilon RI signaling pathway 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
511 Fc epsilon RI signaling pathway 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
512 Fc epsilon RI signaling pathway 💬
 1件: TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
513 Fc epsilon RI signaling pathway 💬
 1件: TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
514 Fc gamma R-mediated phagocytosis 💬
 1件: MAP2K1 💬 D10604 💬 Binimetinib 1件: 34 💬
515 Fc gamma R-mediated phagocytosis 💬
 1件: MAP2K1 💬 D09666 💬 Selumetinib 1件: 34 💬
516 Fc gamma R-mediated phagocytosis 💬
 1件: MAP2K1 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
517 Fc gamma R-mediated phagocytosis 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
518 Fc gamma R-mediated phagocytosis 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
519 Fluid shear stress and atherosclerosis 💬
 1件: BMPR2 💬 D03779 💬 Dibotermin alfa 1件: 34 💬
520 Fluid shear stress and atherosclerosis 💬
 4件: CCL2, IL1A, IL1B, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
521 Fluid shear stress and atherosclerosis 💬
 1件: KDR 💬 D03218 💬 Axitinib 1件: 34 💬
522 Fluid shear stress and atherosclerosis 💬
 1件: KDR 💬 D10062 💬 Cabozantinib 1件: 34 💬
523 Fluid shear stress and atherosclerosis 💬
 1件: KDR 💬 D08881 💬 Cediranib 1件: 34 💬
524 Fluid shear stress and atherosclerosis 💬
 1件: KDR 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
525 Fluid shear stress and atherosclerosis 💬
 1件: KDR 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
526 Fluid shear stress and atherosclerosis 💬
 1件: KDR 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
527 Fluid shear stress and atherosclerosis 💬
 1件: KDR 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
528 Fluid shear stress and atherosclerosis 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
529 Fluid shear stress and atherosclerosis 💬
 1件: TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
530 Fluid shear stress and atherosclerosis 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
531 Fluid shear stress and atherosclerosis 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
532 Focal adhesion 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
533 Focal adhesion 💬
 5件: BRAF, FLT4, KDR, PDGFRB, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
534 Focal adhesion 💬
 5件: BRAF, FLT4, KDR, PDGFRB, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
535 Focal adhesion 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
536 Focal adhesion 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
537 Focal adhesion 💬
 2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
538 Focal adhesion 💬
 2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
539 Focal adhesion 💬
 3件: FLT1, FLT4, KDR 💬 D03218 💬 Axitinib 1件: 34 💬
540 Focal adhesion 💬
 3件: FLT1, FLT4, KDR 💬 D08881 💬 Cediranib 1件: 34 💬
541 Focal adhesion 💬
 5件: FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
542 Focal adhesion 💬
 5件: FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
543 Focal adhesion 💬
 2件: KDR, MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
544 Focal adhesion 💬
 1件: MAP2K1 💬 D10604 💬 Binimetinib 1件: 34 💬
545 Focal adhesion 💬
 1件: MAP2K1 💬 D09666 💬 Selumetinib 1件: 34 💬
546 Focal adhesion 💬
 1件: MAP2K1 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
547 Focal adhesion 💬
 1件: PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
548 Focal adhesion 💬
 1件: PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
549 Focal adhesion 💬
 2件: PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
550 Focal adhesion 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
551 Focal adhesion 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
552 Folate biosynthesis 💬
 2件: DHFR, DHFR2 💬 D00142 💬 Methotrexate 38件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 283, 284, 285, 286, 326, 331 💬
553 Folate biosynthesis 💬
 2件: DHFR, DHFR2 💬 D02115 💬 Methotrexate 38件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 283, 284, 285, 286, 326, 331 💬
554 FoxO signaling pathway 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
555 FoxO signaling pathway 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
556 FoxO signaling pathway 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
557 FoxO signaling pathway 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
558 FoxO signaling pathway 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
559 FoxO signaling pathway 💬
 1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
560 FoxO signaling pathway 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
561 FoxO signaling pathway 💬
 2件: IL10, IL6 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
562 FoxO signaling pathway 💬
 1件: IL6 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
563 FoxO signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
564 FoxO signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
565 FoxO signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
566 GABAergic synapse 💬
 3件: ABAT, GAD1, GAD2 💬 D00399 💬 Valproic acid 17件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 127, 222, 233, 256, 331 💬
567 GABAergic synapse 💬
 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 D00549 💬 Propofol 10件:  6 , 21, 22, 34, 46, 70, 75, 84, 98, 296 💬
568 Gap junction 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
569 Gap junction 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
570 Gap junction 💬
 1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
571 Gap junction 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
572 Gap junction 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
573 Gap junction 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
574 Gap junction 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
575 Gap junction 💬
 1件: PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
576 Gap junction 💬
 1件: PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
577 Gap junction 💬
 2件: PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
578 Gap junction 💬
 2件: PDGFRA, PDGFRB 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
579 Gap junction 💬
 2件: PDGFRA, PDGFRB 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
580 Gap junction 💬
 2件: PDGFRB, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
581 Gap junction 💬
 2件: PDGFRB, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
582 Gap junction 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D01068 💬 Vinblastine 2件: 34, 65 💬
583 Gap junction 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08675 💬 Vinblastine 2件: 34, 65 💬
584 Gap junction 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D02197 💬 Vincristine 4件: 26, 34, 65, 331 💬
585 Gap junction 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08679 💬 Vincristine 4件: 26, 34, 65, 331 💬
586 Gastric cancer 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
587 Gastric cancer 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
588 Gastric cancer 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
589 Gastric cancer 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
590 Gastric cancer 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
591 Gastric cancer 💬
 2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
592 Gastric cancer 💬
 2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
593 Gastric cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
594 Gastric cancer 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
595 Gastric cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
596 Gastric cancer 💬
 1件: MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
597 Gastric cancer 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
598 Gastric cancer 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
599 Gastric cancer 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
600 Glioma 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
601 Glioma 💬
 3件: BRAF, PDGFRB, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
602 Glioma 💬
 3件: BRAF, PDGFRB, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
603 Glioma 💬
 2件: CDK4, CDK6 💬 D10688 💬 Abemaciclib 1件: 34 💬
604 Glioma 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
605 Glioma 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
606 Glioma 💬
 1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
607 Glioma 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
608 Glioma 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
609 Glioma 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
610 Glioma 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
611 Glioma 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
612 Glioma 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
613 Glioma 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
614 Glioma 💬
 1件: PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
615 Glioma 💬
 1件: PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
616 Glioma 💬
 2件: PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
617 Glioma 💬
 2件: PDGFRA, PDGFRB 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
618 Glioma 💬
 2件: PDGFRA, PDGFRB 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
619 GnRH secretion 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 D00399 💬 Valproic acid 17件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 127, 222, 233, 256, 331 💬
620 GnRH secretion 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
621 GnRH secretion 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
622 GnRH secretion 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
623 GnRH secretion 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
624 GnRH secretion 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
625 GnRH signaling pathway 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
626 GnRH signaling pathway 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
627 GnRH signaling pathway 💬
 1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
628 GnRH signaling pathway 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
629 GnRH signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
630 GnRH signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
631 GnRH signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
632 GnRH signaling pathway 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
633 GnRH signaling pathway 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
634 Graft-versus-host disease 💬
 4件: IL1A, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
635 Graft-versus-host disease 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
636 Graft-versus-host disease 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
637 Growth hormone synthesis, secretion and action 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
638 Growth hormone synthesis, secretion and action 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
639 Growth hormone synthesis, secretion and action 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
640 Growth hormone synthesis, secretion and action 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
641 Growth hormone synthesis, secretion and action 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
642 Growth hormone synthesis, secretion and action 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
643 Growth hormone synthesis, secretion and action 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
644 Growth hormone synthesis, secretion and action 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
645 Hematopoietic cell lineage 💬
 3件: CSF1, FLT3, KIT 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
646 Hematopoietic cell lineage 💬
 3件: CSF1, FLT3, KIT 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
647 Hematopoietic cell lineage 💬
 3件: CSF1R, FLT3, KIT 💬 D11270 💬 Pexidartinib 1件: 34 💬
648 Hematopoietic cell lineage 💬
 1件: CSF3R 💬 D03235 💬 Filgrastim 34件:  2 ,  6 , 11, 13, 16, 25, 26, 28, 34, 35, 36, 38, 40, 41, 42, 45, 46, 47, 49, 51, 57, 60, 62, 65, 85, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
649 Hematopoietic cell lineage 💬
 2件: FLT3, KIT 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
650 Hematopoietic cell lineage 💬
 2件: FLT3, KIT 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
651 Hematopoietic cell lineage 💬
 4件: IL1A, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
652 Hematopoietic cell lineage 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
653 Hematopoietic cell lineage 💬
 1件: KIT 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
654 Hematopoietic cell lineage 💬
 1件: KIT 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
655 Hematopoietic cell lineage 💬
 1件: KIT 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
656 Hematopoietic cell lineage 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
657 Hepatitis B 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
658 Hepatitis B 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
659 Hepatitis B 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
660 Hepatitis B 💬
 1件: IFNAR1 💬 D02745 💬 Interferon alfa-2b 2件: 25, 34 💬
661 Hepatitis B 💬
 2件: IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
662 Hepatitis B 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
663 Hepatitis B 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
664 Hepatitis B 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
665 Hepatitis B 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
666 Hepatitis B 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
667 Hepatitis C 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
668 Hepatitis C 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
669 Hepatitis C 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
670 Hepatitis C 💬
 2件: CDK4, CDK6 💬 D10688 💬 Abemaciclib 1件: 34 💬
671 Hepatitis C 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
672 Hepatitis C 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
673 Hepatitis C 💬
 1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
674 Hepatitis C 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
675 Hepatitis C 💬
 2件: IFNAR1, IFNAR2 💬 D02745 💬 Interferon alfa-2b 2件: 25, 34 💬
676 Hepatitis C 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
677 Hepatitis C 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
678 Hepatitis C 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
679 Hepatitis C 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
680 Hepatitis C 💬
 1件: TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
681 Hepatitis C 💬
 1件: TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
682 Hepatocellular carcinoma 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
683 Hepatocellular carcinoma 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
684 Hepatocellular carcinoma 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
685 Hepatocellular carcinoma 💬
 2件: CDK4, CDK6 💬 D10688 💬 Abemaciclib 1件: 34 💬
686 Hepatocellular carcinoma 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
687 Hepatocellular carcinoma 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
688 Hepatocellular carcinoma 💬
 1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
689 Hepatocellular carcinoma 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
690 Hepatocellular carcinoma 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
691 Hepatocellular carcinoma 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
692 Hepatocellular carcinoma 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
693 Hepatocellular carcinoma 💬
 1件: MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
694 Hepatocellular carcinoma 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
695 Hepatocellular carcinoma 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
696 Hepatocellular carcinoma 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
697 Herpes simplex virus 1 infection 💬
 4件: CCL2, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
698 Herpes simplex virus 1 infection 💬
 2件: IFNAR1, IFNAR2 💬 D02745 💬 Interferon alfa-2b 2件: 25, 34 💬
699 Herpes simplex virus 1 infection 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
700 Herpes simplex virus 1 infection 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
701 Herpes simplex virus 1 infection 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
702 Herpes simplex virus 1 infection 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
703 Herpes simplex virus 1 infection 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
704 HIF-1 signaling pathway 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
705 HIF-1 signaling pathway 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
706 HIF-1 signaling pathway 💬
 2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
707 HIF-1 signaling pathway 💬
 2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
708 HIF-1 signaling pathway 💬
 1件: FLT1 💬 D03218 💬 Axitinib 1件: 34 💬
709 HIF-1 signaling pathway 💬
 1件: FLT1 💬 D08881 💬 Cediranib 1件: 34 💬
710 HIF-1 signaling pathway 💬
 1件: FLT1 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
711 HIF-1 signaling pathway 💬
 1件: FLT1 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
712 HIF-1 signaling pathway 💬
 1件: IL6 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
713 HIF-1 signaling pathway 💬
 1件: IL6 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
714 HIF-1 signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
715 HIF-1 signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
716 HIF-1 signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
717 HIF-1 signaling pathway 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
718 HIF-1 signaling pathway 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
719 HIF-1 signaling pathway 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
720 HIF-1 signaling pathway 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
721 HIF-1 signaling pathway 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
722 Hippo signaling pathway 💬
 1件: BMPR2 💬 D03779 💬 Dibotermin alfa 1件: 34 💬
723 Human cytomegalovirus infection 💬
 4件: CCL2, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
724 Human cytomegalovirus infection 💬
 2件: CDK4, CDK6 💬 D10688 💬 Abemaciclib 1件: 34 💬
725 Human cytomegalovirus infection 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
726 Human cytomegalovirus infection 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
727 Human cytomegalovirus infection 💬
 1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
728 Human cytomegalovirus infection 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
729 Human cytomegalovirus infection 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
730 Human cytomegalovirus infection 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
731 Human cytomegalovirus infection 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
732 Human cytomegalovirus infection 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
733 Human cytomegalovirus infection 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
734 Human cytomegalovirus infection 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
735 Human cytomegalovirus infection 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
736 Human cytomegalovirus infection 💬
 1件: PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
737 Human cytomegalovirus infection 💬
 1件: PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
738 Human cytomegalovirus infection 💬
 1件: PDGFRA 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
739 Human cytomegalovirus infection 💬
 1件: PDGFRA 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
740 Human cytomegalovirus infection 💬
 1件: PDGFRA 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
741 Human cytomegalovirus infection 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271, 300, 337 💬
742 Human cytomegalovirus infection 💬
 1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
743 Human cytomegalovirus infection 💬
 1件: PTGS2 💬 D00567 💬 Celecoxib 10件:  2 ,  3 , 34, 46, 70, 89, 107, 161, 171, 271 💬
744 Human cytomegalovirus infection 💬
 1件: PTGS2 💬 D00903 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
745 Human cytomegalovirus infection 💬
 1件: PTGS2 💬 D00904 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
746 Human cytomegalovirus infection 💬
 1件: PTGS2 💬 D07816 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
747 Human cytomegalovirus infection 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
748 Human cytomegalovirus infection 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
749 Human cytomegalovirus infection 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
750 Human cytomegalovirus infection 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
751 Human cytomegalovirus infection 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
752 Human immunodeficiency virus 1 infection 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
753 Human immunodeficiency virus 1 infection 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
754 Human immunodeficiency virus 1 infection 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
755 Human immunodeficiency virus 1 infection 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
756 Human immunodeficiency virus 1 infection 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
757 Human immunodeficiency virus 1 infection 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
758 Human immunodeficiency virus 1 infection 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
759 Human immunodeficiency virus 1 infection 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
760 Human immunodeficiency virus 1 infection 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
761 Human immunodeficiency virus 1 infection 💬
 1件: TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
762 Human immunodeficiency virus 1 infection 💬
 1件: TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
763 Human papillomavirus infection 💬
 2件: CDK4, CDK6 💬 D10688 💬 Abemaciclib 1件: 34 💬
764 Human papillomavirus infection 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
765 Human papillomavirus infection 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
766 Human papillomavirus infection 💬
 1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
767 Human papillomavirus infection 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
768 Human papillomavirus infection 💬
 2件: IFNAR1, IFNAR2 💬 D02745 💬 Interferon alfa-2b 2件: 25, 34 💬
769 Human papillomavirus infection 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
770 Human papillomavirus infection 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
771 Human papillomavirus infection 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
772 Human papillomavirus infection 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
773 Human papillomavirus infection 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
774 Human papillomavirus infection 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
775 Human papillomavirus infection 💬
 1件: PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
776 Human papillomavirus infection 💬
 1件: PDGFRB 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
777 Human papillomavirus infection 💬
 1件: PDGFRB 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
778 Human papillomavirus infection 💬
 2件: PDGFRB, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
779 Human papillomavirus infection 💬
 2件: PDGFRB, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
780 Human papillomavirus infection 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271, 300, 337 💬
781 Human papillomavirus infection 💬
 1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
782 Human papillomavirus infection 💬
 1件: PTGS2 💬 D00567 💬 Celecoxib 10件:  2 ,  3 , 34, 46, 70, 89, 107, 161, 171, 271 💬
783 Human papillomavirus infection 💬
 1件: PTGS2 💬 D00903 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
784 Human papillomavirus infection 💬
 1件: PTGS2 💬 D00904 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
785 Human papillomavirus infection 💬
 1件: PTGS2 💬 D07816 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
786 Human papillomavirus infection 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
787 Human papillomavirus infection 💬
 1件: TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
788 Human papillomavirus infection 💬
 1件: TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
789 Human papillomavirus infection 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
790 Human papillomavirus infection 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
791 Human T-cell leukemia virus 1 infection 💬
 1件: CDK4 💬 D10688 💬 Abemaciclib 1件: 34 💬
792 Human T-cell leukemia virus 1 infection 💬
 2件: IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
793 Human T-cell leukemia virus 1 infection 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
794 Human T-cell leukemia virus 1 infection 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
795 Human T-cell leukemia virus 1 infection 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
796 Human T-cell leukemia virus 1 infection 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
797 Human T-cell leukemia virus 1 infection 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
798 Huntington disease 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
799 Huntington disease 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
800 Huntington disease 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
801 Huntington disease 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D01068 💬 Vinblastine 2件: 34, 65 💬
802 Huntington disease 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08675 💬 Vinblastine 2件: 34, 65 💬
803 Huntington disease 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D02197 💬 Vincristine 4件: 26, 34, 65, 331 💬
804 Huntington disease 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08679 💬 Vincristine 4件: 26, 34, 65, 331 💬
805 Hypertrophic cardiomyopathy 💬
 2件: IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
806 Hypertrophic cardiomyopathy 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
807 Hypertrophic cardiomyopathy 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
808 IL-17 signaling pathway 💬
 4件: CCL2, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
809 IL-17 signaling pathway 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
810 IL-17 signaling pathway 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271, 300, 337 💬
811 IL-17 signaling pathway 💬
 1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
812 IL-17 signaling pathway 💬
 1件: PTGS2 💬 D00567 💬 Celecoxib 10件:  2 ,  3 , 34, 46, 70, 89, 107, 161, 171, 271 💬
813 IL-17 signaling pathway 💬
 1件: PTGS2 💬 D00903 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
814 IL-17 signaling pathway 💬
 1件: PTGS2 💬 D00904 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
815 IL-17 signaling pathway 💬
 1件: PTGS2 💬 D07816 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
816 IL-17 signaling pathway 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
817 Inflammatory bowel disease 💬
 5件: IL10, IL1A, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
818 Inflammatory bowel disease 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
819 Inflammatory bowel disease 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
820 Inflammatory mediator regulation of TRP channels 💬
 1件: IL1B 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
821 Influenza A 💬
 5件: CCL2, IL1A, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
822 Influenza A 💬
 2件: CDK4, CDK6 💬 D10688 💬 Abemaciclib 1件: 34 💬
823 Influenza A 💬
 2件: IFNAR1, IFNAR2 💬 D02745 💬 Interferon alfa-2b 2件: 25, 34 💬
824 Influenza A 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
825 Influenza A 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
826 Influenza A 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
827 Influenza A 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
828 Influenza A 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
829 Influenza A 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
830 Influenza A 💬
 1件: TLR7 💬 D02500 💬 Imiquimod 2件: 34, 51 💬
831 Influenza A 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
832 Insulin resistance 💬
 2件: IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
833 Insulin resistance 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
834 Insulin resistance 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
835 Insulin resistance 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
836 Insulin resistance 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
837 Insulin resistance 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
838 Insulin signaling pathway 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
839 Insulin signaling pathway 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
840 Insulin signaling pathway 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
841 Insulin signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
842 Insulin signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
843 Insulin signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
844 Insulin signaling pathway 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
845 Insulin signaling pathway 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
846 Insulin signaling pathway 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
847 Intestinal immune network for IgA production 💬
 2件: IL10, IL6 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
848 Intestinal immune network for IgA production 💬
 1件: IL6 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
849 JAK-STAT signaling pathway 💬
 1件: CSF3R 💬 D03235 💬 Filgrastim 34件:  2 ,  6 , 11, 13, 16, 25, 26, 28, 34, 35, 36, 38, 40, 41, 42, 45, 46, 47, 49, 51, 57, 60, 62, 65, 85, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
850 JAK-STAT signaling pathway 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
851 JAK-STAT signaling pathway 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
852 JAK-STAT signaling pathway 💬
 1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
853 JAK-STAT signaling pathway 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
854 JAK-STAT signaling pathway 💬
 2件: IFNAR1, IFNAR2 💬 D02745 💬 Interferon alfa-2b 2件: 25, 34 💬
855 JAK-STAT signaling pathway 💬
 2件: IL10, IL6 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
856 JAK-STAT signaling pathway 💬
 1件: IL6 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
857 JAK-STAT signaling pathway 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
858 JAK-STAT signaling pathway 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
859 JAK-STAT signaling pathway 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
860 JAK-STAT signaling pathway 💬
 1件: PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
861 JAK-STAT signaling pathway 💬
 1件: PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
862 JAK-STAT signaling pathway 💬
 2件: PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
863 JAK-STAT signaling pathway 💬
 2件: PDGFRA, PDGFRB 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
864 JAK-STAT signaling pathway 💬
 2件: PDGFRA, PDGFRB 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
865 JAK-STAT signaling pathway 💬
 2件: PDGFRB, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
866 JAK-STAT signaling pathway 💬
 2件: PDGFRB, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
867 Kaposi sarcoma-associated herpesvirus infection 💬
 2件: CDK4, CDK6 💬 D10688 💬 Abemaciclib 1件: 34 💬
868 Kaposi sarcoma-associated herpesvirus infection 💬
 2件: IFNAR1, IFNAR2 💬 D02745 💬 Interferon alfa-2b 2件: 25, 34 💬
869 Kaposi sarcoma-associated herpesvirus infection 💬
 1件: IL6 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
870 Kaposi sarcoma-associated herpesvirus infection 💬
 1件: IL6 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
871 Kaposi sarcoma-associated herpesvirus infection 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
872 Kaposi sarcoma-associated herpesvirus infection 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
873 Kaposi sarcoma-associated herpesvirus infection 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
874 Kaposi sarcoma-associated herpesvirus infection 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
875 Kaposi sarcoma-associated herpesvirus infection 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
876 Kaposi sarcoma-associated herpesvirus infection 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
877 Kaposi sarcoma-associated herpesvirus infection 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271, 300, 337 💬
878 Kaposi sarcoma-associated herpesvirus infection 💬
 1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
879 Kaposi sarcoma-associated herpesvirus infection 💬
 1件: PTGS2 💬 D00567 💬 Celecoxib 10件:  2 ,  3 , 34, 46, 70, 89, 107, 161, 171, 271 💬
880 Kaposi sarcoma-associated herpesvirus infection 💬
 1件: PTGS2 💬 D00903 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
881 Kaposi sarcoma-associated herpesvirus infection 💬
 1件: PTGS2 💬 D00904 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
882 Kaposi sarcoma-associated herpesvirus infection 💬
 1件: PTGS2 💬 D07816 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
883 Kaposi sarcoma-associated herpesvirus infection 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
884 Kaposi sarcoma-associated herpesvirus infection 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
885 Kaposi sarcoma-associated herpesvirus infection 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
886 Kaposi sarcoma-associated herpesvirus infection 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
887 Legionellosis 💬
 3件: IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
888 Legionellosis 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
889 Legionellosis 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
890 Leishmaniasis 💬
 4件: IL10, IL1A, IL1B, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
891 Leishmaniasis 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271, 300, 337 💬
892 Leishmaniasis 💬
 1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
893 Leishmaniasis 💬
 1件: PTGS2 💬 D00567 💬 Celecoxib 10件:  2 ,  3 , 34, 46, 70, 89, 107, 161, 171, 271 💬
894 Leishmaniasis 💬
 1件: PTGS2 💬 D00903 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
895 Leishmaniasis 💬
 1件: PTGS2 💬 D00904 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
896 Leishmaniasis 💬
 1件: PTGS2 💬 D07816 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
897 Leishmaniasis 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
898 Leishmaniasis 💬
 1件: TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
899 Lipid and atherosclerosis 💬
 4件: CCL2, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
900 Lipid and atherosclerosis 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
901 Lipid and atherosclerosis 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
902 Long-term depression 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
903 Long-term depression 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
904 Long-term depression 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
905 Long-term depression 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
906 Long-term depression 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
907 Long-term depression 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
908 Long-term potentiation 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
909 Long-term potentiation 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
910 Long-term potentiation 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
911 Long-term potentiation 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
912 Long-term potentiation 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
913 Long-term potentiation 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
914 Longevity regulating pathway 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
915 Longevity regulating pathway 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
916 Longevity regulating pathway 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
917 Longevity regulating pathway - multiple species 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
918 Longevity regulating pathway - multiple species 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
919 Longevity regulating pathway - multiple species 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
920 Malaria 💬
 5件: CCL2, IL10, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
921 Malaria 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
922 Malaria 💬
 1件: MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
923 Malaria 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
924 MAPK signaling pathway 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
925 MAPK signaling pathway 💬
 7件: BRAF, FLT3, FLT4, KDR, KIT, PDGFRB, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
926 MAPK signaling pathway 💬
 7件: BRAF, FLT3, FLT4, KDR, KIT, PDGFRB, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
927 MAPK signaling pathway 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 D00399 💬 Valproic acid 17件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 127, 222, 233, 256, 331 💬
928 MAPK signaling pathway 💬
 8件: CSF1, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
929 MAPK signaling pathway 💬
 8件: CSF1, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
930 MAPK signaling pathway 💬
 3件: CSF1R, FLT3, KIT 💬 D11270 💬 Pexidartinib 1件: 34 💬
931 MAPK signaling pathway 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
932 MAPK signaling pathway 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
933 MAPK signaling pathway 💬
 2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
934 MAPK signaling pathway 💬
 2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
935 MAPK signaling pathway 💬
 3件: FLT1, FLT4, KDR 💬 D03218 💬 Axitinib 1件: 34 💬
936 MAPK signaling pathway 💬
 3件: FLT1, FLT4, KDR 💬 D08881 💬 Cediranib 1件: 34 💬
937 MAPK signaling pathway 💬
 3件: IL1A, IL1B, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
938 MAPK signaling pathway 💬
 2件: KDR, MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
939 MAPK signaling pathway 💬
 2件: KIT, PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
940 MAPK signaling pathway 💬
 2件: KIT, PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
941 MAPK signaling pathway 💬
 3件: KIT, PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
942 MAPK signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
943 MAPK signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
944 MAPK signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
945 MAPK signaling pathway 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
946 MAPK signaling pathway 💬
 1件: TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
947 MAPK signaling pathway 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
948 MAPK signaling pathway 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
949 Measles 💬
 2件: CDK4, CDK6 💬 D10688 💬 Abemaciclib 1件: 34 💬
950 Measles 💬
 2件: IFNAR1, IFNAR2 💬 D02745 💬 Interferon alfa-2b 2件: 25, 34 💬
951 Measles 💬
 3件: IL1A, IL1B, IL6 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
952 Measles 💬
 1件: IL6 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
953 Measles 💬
 1件: TLR7 💬 D02500 💬 Imiquimod 2件: 34, 51 💬
954 Melanogenesis 💬
 1件: KIT 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
955 Melanogenesis 💬
 1件: KIT 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
956 Melanogenesis 💬
 1件: KIT 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
957 Melanogenesis 💬
 1件: KIT 💬 D11270 💬 Pexidartinib 1件: 34 💬
958 Melanogenesis 💬
 1件: KIT 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
959 Melanogenesis 💬
 1件: KIT 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
960 Melanogenesis 💬
 2件: KIT, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
961 Melanogenesis 💬
 2件: KIT, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
962 Melanogenesis 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
963 Melanogenesis 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
964 Melanogenesis 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
965 Melanoma 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
966 Melanoma 💬
 3件: BRAF, PDGFRB, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
967 Melanoma 💬
 3件: BRAF, PDGFRB, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
968 Melanoma 💬
 2件: CDK4, CDK6 💬 D10688 💬 Abemaciclib 1件: 34 💬
969 Melanoma 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
970 Melanoma 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
971 Melanoma 💬
 1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
972 Melanoma 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
973 Melanoma 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
974 Melanoma 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
975 Melanoma 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
976 Melanoma 💬
 1件: MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
977 Melanoma 💬
 1件: PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
978 Melanoma 💬
 1件: PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
979 Melanoma 💬
 2件: PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
980 Melanoma 💬
 2件: PDGFRA, PDGFRB 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
981 Melanoma 💬
 2件: PDGFRA, PDGFRB 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
982 Metabolic pathways 💬
 4件: ABAT, ALDH5A1, GAD1, GAD2 💬 D00399 💬 Valproic acid 17件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 127, 222, 233, 256, 331 💬
983 Metabolic pathways 💬
 2件: DHFR, DHFR2 💬 D00142 💬 Methotrexate 38件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 283, 284, 285, 286, 326, 331 💬
984 Metabolic pathways 💬
 2件: DHFR, DHFR2 💬 D02115 💬 Methotrexate 38件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 283, 284, 285, 286, 326, 331 💬
985 Metabolic pathways 💬
 1件: HMGCR 💬 D00359 💬 Lovastatin 11件:  6 , 34, 46, 79, 156, 160, 195, 206, 263, 280, 310 💬
986 Metabolic pathways 💬
 1件: HMGCR 💬 D00434 💬 Simvastatin 21件:  6 , 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬
987 Metabolic pathways 💬
 2件: PTGS1, PTGS2 💬 D00217 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271, 300, 337 💬
988 Metabolic pathways 💬
 2件: PTGS1, PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
989 Metabolic pathways 💬
 2件: PTGS1, PTGS2 💬 D00903 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
990 Metabolic pathways 💬
 2件: PTGS1, PTGS2 💬 D00904 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
991 Metabolic pathways 💬
 2件: PTGS1, PTGS2 💬 D07816 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
992 Metabolic pathways 💬
 1件: PTGS2 💬 D00567 💬 Celecoxib 10件:  2 ,  3 , 34, 46, 70, 89, 107, 161, 171, 271 💬
993 MicroRNAs in cancer 💬
 2件: ABL1, PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
994 MicroRNAs in cancer 💬
 2件: ABL1, PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
995 MicroRNAs in cancer 💬
 3件: ABL1, PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
996 MicroRNAs in cancer 💬
 1件: BMPR2 💬 D03779 💬 Dibotermin alfa 1件: 34 💬
997 MicroRNAs in cancer 💬
 1件: CDK6 💬 D10688 💬 Abemaciclib 1件: 34 💬
998 MicroRNAs in cancer 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
999 MicroRNAs in cancer 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
1000 MicroRNAs in cancer 💬
 2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
1001 MicroRNAs in cancer 💬
 2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
1002 MicroRNAs in cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1003 MicroRNAs in cancer 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1004 MicroRNAs in cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1005 MicroRNAs in cancer 💬
 1件: MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
1006 MicroRNAs in cancer 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1007 MicroRNAs in cancer 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
1008 MicroRNAs in cancer 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1009 MicroRNAs in cancer 💬
 2件: PDGFRA, PDGFRB 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
1010 MicroRNAs in cancer 💬
 2件: PDGFRA, PDGFRB 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
1011 MicroRNAs in cancer 💬
 2件: PDGFRB, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1012 MicroRNAs in cancer 💬
 2件: PDGFRB, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1013 MicroRNAs in cancer 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271, 300, 337 💬
1014 MicroRNAs in cancer 💬
 1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
1015 MicroRNAs in cancer 💬
 1件: PTGS2 💬 D00567 💬 Celecoxib 10件:  2 ,  3 , 34, 46, 70, 89, 107, 161, 171, 271 💬
1016 MicroRNAs in cancer 💬
 1件: PTGS2 💬 D00903 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1017 MicroRNAs in cancer 💬
 1件: PTGS2 💬 D00904 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1018 MicroRNAs in cancer 💬
 1件: PTGS2 💬 D07816 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1019 MicroRNAs in cancer 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
1020 MicroRNAs in cancer 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
1021 Mineral absorption 💬
 1件: VDR 💬 D00188 💬 Cholecalciferol 25件:  6 , 13, 19, 20, 28, 34, 46, 49, 51, 53, 56, 60, 65, 75, 84, 85, 96, 97, 98, 162, 202, 228, 271, 298, 299 💬
1022 Morphine addiction 💬
 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 D00549 💬 Propofol 10件:  6 , 21, 22, 34, 46, 70, 75, 84, 98, 296 💬
1023 mTOR signaling pathway 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
1024 mTOR signaling pathway 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1025 mTOR signaling pathway 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1026 mTOR signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1027 mTOR signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1028 mTOR signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1029 mTOR signaling pathway 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1030 mTOR signaling pathway 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
1031 mTOR signaling pathway 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1032 mTOR signaling pathway 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1033 mTOR signaling pathway 💬
 1件: TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1034 mTOR signaling pathway 💬
 1件: TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1035 Natural killer cell mediated cytotoxicity 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
1036 Natural killer cell mediated cytotoxicity 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1037 Natural killer cell mediated cytotoxicity 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1038 Natural killer cell mediated cytotoxicity 💬
 2件: IFNAR1, IFNAR2 💬 D02745 💬 Interferon alfa-2b 2件: 25, 34 💬
1039 Natural killer cell mediated cytotoxicity 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1040 Natural killer cell mediated cytotoxicity 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1041 Natural killer cell mediated cytotoxicity 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1042 Natural killer cell mediated cytotoxicity 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1043 Natural killer cell mediated cytotoxicity 💬
 1件: TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1044 Natural killer cell mediated cytotoxicity 💬
 1件: TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1045 Necroptosis 💬
 2件: IFNAR1, IFNAR2 💬 D02745 💬 Interferon alfa-2b 2件: 25, 34 💬
1046 Necroptosis 💬
 3件: IL1A, IL1B, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1047 Necroptosis 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1048 Necroptosis 💬
 1件: TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1049 Neuroactive ligand-receptor interaction 💬
 3件: ADRA2A, ADRA2B, ADRA2C 💬 D00514 💬 Dexmedetomidine 13件:  2 ,  4 ,  6 , 21, 34, 46, 70, 107, 113, 212, 215, 226, 280 💬
1050 Neuroactive ligand-receptor interaction 💬
 3件: ADRA2A, ADRA2B, ADRA2C 💬 D01205 💬 Dexmedetomidine 13件:  2 ,  4 ,  6 , 21, 34, 46, 70, 107, 113, 212, 215, 226, 280 💬
1051 Neuroactive ligand-receptor interaction 💬
 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 D00549 💬 Propofol 10件:  6 , 21, 22, 34, 46, 70, 75, 84, 98, 296 💬
1052 Neurotrophin signaling pathway 💬
 1件: ABL1 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1053 Neurotrophin signaling pathway 💬
 1件: ABL1 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1054 Neurotrophin signaling pathway 💬
 1件: ABL1 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
1055 Neurotrophin signaling pathway 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
1056 Neurotrophin signaling pathway 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1057 Neurotrophin signaling pathway 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1058 Neurotrophin signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1059 Neurotrophin signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1060 Neurotrophin signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1061 Neutrophil extracellular trap formation 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1062 Neutrophil extracellular trap formation 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1063 Neutrophil extracellular trap formation 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1064 Neutrophil extracellular trap formation 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1065 Neutrophil extracellular trap formation 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
1066 Neutrophil extracellular trap formation 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1067 Neutrophil extracellular trap formation 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1068 Neutrophil extracellular trap formation 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1069 Neutrophil extracellular trap formation 💬
 1件: TLR7 💬 D02500 💬 Imiquimod 2件: 34, 51 💬
1070 NF-kappa B signaling pathway 💬
 2件: IL1B, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1071 NF-kappa B signaling pathway 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271, 300, 337 💬
1072 NF-kappa B signaling pathway 💬
 1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
1073 NF-kappa B signaling pathway 💬
 1件: PTGS2 💬 D00567 💬 Celecoxib 10件:  2 ,  3 , 34, 46, 70, 89, 107, 161, 171, 271 💬
1074 NF-kappa B signaling pathway 💬
 1件: PTGS2 💬 D00903 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1075 NF-kappa B signaling pathway 💬
 1件: PTGS2 💬 D00904 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1076 NF-kappa B signaling pathway 💬
 1件: PTGS2 💬 D07816 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1077 NF-kappa B signaling pathway 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1078 NF-kappa B signaling pathway 💬
 1件: TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1079 Nicotine addiction 💬
 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 D00549 💬 Propofol 10件:  6 , 21, 22, 34, 46, 70, 75, 84, 98, 296 💬
1080 NOD-like receptor signaling pathway 💬
 4件: CCL2, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1081 NOD-like receptor signaling pathway 💬
 2件: IFNAR1, IFNAR2 💬 D02745 💬 Interferon alfa-2b 2件: 25, 34 💬
1082 NOD-like receptor signaling pathway 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1083 NOD-like receptor signaling pathway 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1084 Non-alcoholic fatty liver disease 💬
 4件: IL1A, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1085 Non-alcoholic fatty liver disease 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1086 Non-alcoholic fatty liver disease 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1087 Non-small cell lung cancer 💬
 1件: ALK 💬 D10866 💬 Brigatinib 1件: 34 💬
1088 Non-small cell lung cancer 💬
 1件: ALK 💬 D09731 💬 Crizotinib 1件: 34 💬
1089 Non-small cell lung cancer 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
1090 Non-small cell lung cancer 💬
 3件: BRAF, RAF1, RET 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1091 Non-small cell lung cancer 💬
 3件: BRAF, RAF1, RET 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1092 Non-small cell lung cancer 💬
 2件: CDK4, CDK6 💬 D10688 💬 Abemaciclib 1件: 34 💬
1093 Non-small cell lung cancer 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
1094 Non-small cell lung cancer 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
1095 Non-small cell lung cancer 💬
 2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
1096 Non-small cell lung cancer 💬
 2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
1097 Non-small cell lung cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1098 Non-small cell lung cancer 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1099 Non-small cell lung cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1100 Non-small cell lung cancer 💬
 1件: MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
1101 Non-small cell lung cancer 💬
 1件: RET 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
1102 Non-small cell lung cancer 💬
 1件: RET 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
1103 One carbon pool by folate 💬
 2件: DHFR, DHFR2 💬 D00142 💬 Methotrexate 38件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 283, 284, 285, 286, 326, 331 💬
1104 One carbon pool by folate 💬
 2件: DHFR, DHFR2 💬 D02115 💬 Methotrexate 38件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 283, 284, 285, 286, 326, 331 💬
1105 Oocyte meiosis 💬
 1件: MAP2K1 💬 D10604 💬 Binimetinib 1件: 34 💬
1106 Oocyte meiosis 💬
 1件: MAP2K1 💬 D09666 💬 Selumetinib 1件: 34 💬
1107 Oocyte meiosis 💬
 1件: MAP2K1 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1108 Osteoclast differentiation 💬
 1件: CSF1 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
1109 Osteoclast differentiation 💬
 1件: CSF1 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
1110 Osteoclast differentiation 💬
 1件: CSF1R 💬 D11270 💬 Pexidartinib 1件: 34 💬
1111 Osteoclast differentiation 💬
 2件: IFNAR1, IFNAR2 💬 D02745 💬 Interferon alfa-2b 2件: 25, 34 💬
1112 Osteoclast differentiation 💬
 3件: IL1A, IL1B, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1113 Osteoclast differentiation 💬
 1件: MAP2K1 💬 D10604 💬 Binimetinib 1件: 34 💬
1114 Osteoclast differentiation 💬
 1件: MAP2K1 💬 D09666 💬 Selumetinib 1件: 34 💬
1115 Osteoclast differentiation 💬
 1件: MAP2K1 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1116 Osteoclast differentiation 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1117 Osteoclast differentiation 💬
 1件: TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1118 Ovarian steroidogenesis 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271, 300, 337 💬
1119 Ovarian steroidogenesis 💬
 1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
1120 Ovarian steroidogenesis 💬
 1件: PTGS2 💬 D00567 💬 Celecoxib 10件:  2 ,  3 , 34, 46, 70, 89, 107, 161, 171, 271 💬
1121 Ovarian steroidogenesis 💬
 1件: PTGS2 💬 D00903 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1122 Ovarian steroidogenesis 💬
 1件: PTGS2 💬 D00904 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1123 Ovarian steroidogenesis 💬
 1件: PTGS2 💬 D07816 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1124 Oxytocin signaling pathway 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
1125 Oxytocin signaling pathway 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
1126 Oxytocin signaling pathway 💬
 1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
1127 Oxytocin signaling pathway 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
1128 Oxytocin signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1129 Oxytocin signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1130 Oxytocin signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1131 Oxytocin signaling pathway 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271, 300, 337 💬
1132 Oxytocin signaling pathway 💬
 1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
1133 Oxytocin signaling pathway 💬
 1件: PTGS2 💬 D00567 💬 Celecoxib 10件:  2 ,  3 , 34, 46, 70, 89, 107, 161, 171, 271 💬
1134 Oxytocin signaling pathway 💬
 1件: PTGS2 💬 D00903 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1135 Oxytocin signaling pathway 💬
 1件: PTGS2 💬 D00904 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1136 Oxytocin signaling pathway 💬
 1件: PTGS2 💬 D07816 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1137 Oxytocin signaling pathway 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1138 Oxytocin signaling pathway 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1139 p53 signaling pathway 💬
 2件: CDK4, CDK6 💬 D10688 💬 Abemaciclib 1件: 34 💬
1140 Pancreatic cancer 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
1141 Pancreatic cancer 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1142 Pancreatic cancer 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1143 Pancreatic cancer 💬
 2件: CDK4, CDK6 💬 D10688 💬 Abemaciclib 1件: 34 💬
1144 Pancreatic cancer 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
1145 Pancreatic cancer 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
1146 Pancreatic cancer 💬
 2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
1147 Pancreatic cancer 💬
 2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
1148 Pancreatic cancer 💬
 1件: MAP2K1 💬 D10604 💬 Binimetinib 1件: 34 💬
1149 Pancreatic cancer 💬
 1件: MAP2K1 💬 D09666 💬 Selumetinib 1件: 34 💬
1150 Pancreatic cancer 💬
 1件: MAP2K1 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1151 Pancreatic cancer 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1152 Pancreatic cancer 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
1153 Pancreatic cancer 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1154 Pancreatic cancer 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
1155 Pancreatic cancer 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
1156 Parathyroid hormone synthesis, secretion and action 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
1157 Parathyroid hormone synthesis, secretion and action 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1158 Parathyroid hormone synthesis, secretion and action 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1159 Parathyroid hormone synthesis, secretion and action 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
1160 Parathyroid hormone synthesis, secretion and action 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
1161 Parathyroid hormone synthesis, secretion and action 💬
 1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
1162 Parathyroid hormone synthesis, secretion and action 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
1163 Parathyroid hormone synthesis, secretion and action 💬
 1件: MAP2K1 💬 D10604 💬 Binimetinib 1件: 34 💬
1164 Parathyroid hormone synthesis, secretion and action 💬
 1件: MAP2K1 💬 D09666 💬 Selumetinib 1件: 34 💬
1165 Parathyroid hormone synthesis, secretion and action 💬
 1件: MAP2K1 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1166 Parathyroid hormone synthesis, secretion and action 💬
 1件: VDR 💬 D00188 💬 Cholecalciferol 25件:  6 , 13, 19, 20, 28, 34, 46, 49, 51, 53, 56, 60, 65, 75, 84, 85, 96, 97, 98, 162, 202, 228, 271, 298, 299 💬
1167 Parkinson disease 💬
 1件: SLC6A3 💬 D01296 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
1168 Parkinson disease 💬
 1件: SLC6A3 💬 D04999 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
1169 Parkinson disease 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D01068 💬 Vinblastine 2件: 34, 65 💬
1170 Parkinson disease 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08675 💬 Vinblastine 2件: 34, 65 💬
1171 Parkinson disease 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D02197 💬 Vincristine 4件: 26, 34, 65, 331 💬
1172 Parkinson disease 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08679 💬 Vincristine 4件: 26, 34, 65, 331 💬
1173 Pathogenic Escherichia coli infection 💬
 1件: ABL1 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1174 Pathogenic Escherichia coli infection 💬
 1件: ABL1 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1175 Pathogenic Escherichia coli infection 💬
 1件: ABL1 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
1176 Pathogenic Escherichia coli infection 💬
 3件: IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1177 Pathogenic Escherichia coli infection 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1178 Pathogenic Escherichia coli infection 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1179 Pathogenic Escherichia coli infection 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D01068 💬 Vinblastine 2件: 34, 65 💬
1180 Pathogenic Escherichia coli infection 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08675 💬 Vinblastine 2件: 34, 65 💬
1181 Pathogenic Escherichia coli infection 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D02197 💬 Vincristine 4件: 26, 34, 65, 331 💬
1182 Pathogenic Escherichia coli infection 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08679 💬 Vincristine 4件: 26, 34, 65, 331 💬
1183 Pathways in cancer 💬
 3件: ABL1, KIT, PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1184 Pathways in cancer 💬
 3件: ABL1, KIT, PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1185 Pathways in cancer 💬
 4件: ABL1, KIT, PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
1186 Pathways in cancer 💬
 1件: ALK 💬 D10866 💬 Brigatinib 1件: 34 💬
1187 Pathways in cancer 💬
 1件: ALK 💬 D09731 💬 Crizotinib 1件: 34 💬
1188 Pathways in cancer 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
1189 Pathways in cancer 💬
 7件: BRAF, FLT3, FLT4, KIT, PDGFRB, RAF1, RET 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1190 Pathways in cancer 💬
 7件: BRAF, FLT3, FLT4, KIT, PDGFRB, RAF1, RET 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1191 Pathways in cancer 💬
 2件: CDK4, CDK6 💬 D10688 💬 Abemaciclib 1件: 34 💬
1192 Pathways in cancer 💬
 3件: CSF1R, FLT3, KIT 💬 D11270 💬 Pexidartinib 1件: 34 💬
1193 Pathways in cancer 💬
 1件: CSF3R 💬 D03235 💬 Filgrastim 34件:  2 ,  6 , 11, 13, 16, 25, 26, 28, 34, 35, 36, 38, 40, 41, 42, 45, 46, 47, 49, 51, 57, 60, 62, 65, 85, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
1194 Pathways in cancer 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
1195 Pathways in cancer 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
1196 Pathways in cancer 💬
 2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
1197 Pathways in cancer 💬
 2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
1198 Pathways in cancer 💬
 6件: FLT3, FLT4, KIT, PDGFRA, PDGFRB, RET 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
1199 Pathways in cancer 💬
 6件: FLT3, FLT4, KIT, PDGFRA, PDGFRB, RET 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
1200 Pathways in cancer 💬
 1件: FLT4 💬 D03218 💬 Axitinib 1件: 34 💬
1201 Pathways in cancer 💬
 1件: FLT4 💬 D08881 💬 Cediranib 1件: 34 💬
1202 Pathways in cancer 💬
 2件: IFNAR1, IFNAR2 💬 D02745 💬 Interferon alfa-2b 2件: 25, 34 💬
1203 Pathways in cancer 💬
 1件: IL6 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1204 Pathways in cancer 💬
 1件: IL6 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1205 Pathways in cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1206 Pathways in cancer 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1207 Pathways in cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1208 Pathways in cancer 💬
 1件: MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
1209 Pathways in cancer 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1210 Pathways in cancer 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
1211 Pathways in cancer 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1212 Pathways in cancer 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271, 300, 337 💬
1213 Pathways in cancer 💬
 1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
1214 Pathways in cancer 💬
 1件: PTGS2 💬 D00567 💬 Celecoxib 10件:  2 ,  3 , 34, 46, 70, 89, 107, 161, 171, 271 💬
1215 Pathways in cancer 💬
 1件: PTGS2 💬 D00903 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1216 Pathways in cancer 💬
 1件: PTGS2 💬 D00904 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1217 Pathways in cancer 💬
 1件: PTGS2 💬 D07816 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1218 Pathways in cancer 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
1219 Pathways in cancer 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
1220 Pathways of neurodegeneration - multiple diseases 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
1221 Pathways of neurodegeneration - multiple diseases 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1222 Pathways of neurodegeneration - multiple diseases 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1223 Pathways of neurodegeneration - multiple diseases 💬
 1件: CSF1 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
1224 Pathways of neurodegeneration - multiple diseases 💬
 1件: CSF1 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
1225 Pathways of neurodegeneration - multiple diseases 💬
 4件: IL1A, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1226 Pathways of neurodegeneration - multiple diseases 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1227 Pathways of neurodegeneration - multiple diseases 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1228 Pathways of neurodegeneration - multiple diseases 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1229 Pathways of neurodegeneration - multiple diseases 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1230 Pathways of neurodegeneration - multiple diseases 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1231 Pathways of neurodegeneration - multiple diseases 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
1232 Pathways of neurodegeneration - multiple diseases 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1233 Pathways of neurodegeneration - multiple diseases 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271, 300, 337 💬
1234 Pathways of neurodegeneration - multiple diseases 💬
 1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
1235 Pathways of neurodegeneration - multiple diseases 💬
 1件: PTGS2 💬 D00567 💬 Celecoxib 10件:  2 ,  3 , 34, 46, 70, 89, 107, 161, 171, 271 💬
1236 Pathways of neurodegeneration - multiple diseases 💬
 1件: PTGS2 💬 D00903 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1237 Pathways of neurodegeneration - multiple diseases 💬
 1件: PTGS2 💬 D00904 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1238 Pathways of neurodegeneration - multiple diseases 💬
 1件: PTGS2 💬 D07816 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1239 Pathways of neurodegeneration - multiple diseases 💬
 1件: SLC6A3 💬 D01296 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
1240 Pathways of neurodegeneration - multiple diseases 💬
 1件: SLC6A3 💬 D04999 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
1241 Pathways of neurodegeneration - multiple diseases 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1242 Pathways of neurodegeneration - multiple diseases 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D01068 💬 Vinblastine 2件: 34, 65 💬
1243 Pathways of neurodegeneration - multiple diseases 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08675 💬 Vinblastine 2件: 34, 65 💬
1244 Pathways of neurodegeneration - multiple diseases 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D02197 💬 Vincristine 4件: 26, 34, 65, 331 💬
1245 Pathways of neurodegeneration - multiple diseases 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08679 💬 Vincristine 4件: 26, 34, 65, 331 💬
1246 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 1件: ALK 💬 D10866 💬 Brigatinib 1件: 34 💬
1247 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 1件: ALK 💬 D09731 💬 Crizotinib 1件: 34 💬
1248 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
1249 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
1250 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
1251 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
1252 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1253 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1254 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1255 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1256 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
1257 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1258 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1259 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1260 Pertussis 💬
 5件: IL10, IL1A, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1261 Pertussis 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1262 Pertussis 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1263 Phagosome 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D01068 💬 Vinblastine 2件: 34, 65 💬
1264 Phagosome 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08675 💬 Vinblastine 2件: 34, 65 💬
1265 Phagosome 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D02197 💬 Vincristine 4件: 26, 34, 65, 331 💬
1266 Phagosome 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08679 💬 Vincristine 4件: 26, 34, 65, 331 💬
1267 Phospholipase D signaling pathway 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
1268 Phospholipase D signaling pathway 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
1269 Phospholipase D signaling pathway 💬
 1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
1270 Phospholipase D signaling pathway 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
1271 Phospholipase D signaling pathway 💬
 1件: KIT 💬 D11270 💬 Pexidartinib 1件: 34 💬
1272 Phospholipase D signaling pathway 💬
 2件: KIT, PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1273 Phospholipase D signaling pathway 💬
 2件: KIT, PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1274 Phospholipase D signaling pathway 💬
 3件: KIT, PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
1275 Phospholipase D signaling pathway 💬
 3件: KIT, PDGFRA, PDGFRB 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
1276 Phospholipase D signaling pathway 💬
 3件: KIT, PDGFRA, PDGFRB 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
1277 Phospholipase D signaling pathway 💬
 3件: KIT, PDGFRB, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1278 Phospholipase D signaling pathway 💬
 3件: KIT, PDGFRB, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1279 Phospholipase D signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1280 Phospholipase D signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1281 Phospholipase D signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1282 Phospholipase D signaling pathway 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1283 Phospholipase D signaling pathway 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
1284 Phospholipase D signaling pathway 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1285 PI3K-Akt signaling pathway 💬
 2件: CDK4, CDK6 💬 D10688 💬 Abemaciclib 1件: 34 💬
1286 PI3K-Akt signaling pathway 💬
 8件: CSF1, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
1287 PI3K-Akt signaling pathway 💬
 8件: CSF1, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
1288 PI3K-Akt signaling pathway 💬
 3件: CSF1R, FLT3, KIT 💬 D11270 💬 Pexidartinib 1件: 34 💬
1289 PI3K-Akt signaling pathway 💬
 1件: CSF3R 💬 D03235 💬 Filgrastim 34件:  2 ,  6 , 11, 13, 16, 25, 26, 28, 34, 35, 36, 38, 40, 41, 42, 45, 46, 47, 49, 51, 57, 60, 62, 65, 85, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
1290 PI3K-Akt signaling pathway 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
1291 PI3K-Akt signaling pathway 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
1292 PI3K-Akt signaling pathway 💬
 2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
1293 PI3K-Akt signaling pathway 💬
 2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
1294 PI3K-Akt signaling pathway 💬
 3件: FLT1, FLT4, KDR 💬 D03218 💬 Axitinib 1件: 34 💬
1295 PI3K-Akt signaling pathway 💬
 3件: FLT1, FLT4, KDR 💬 D08881 💬 Cediranib 1件: 34 💬
1296 PI3K-Akt signaling pathway 💬
 6件: FLT3, FLT4, KDR, KIT, PDGFRB, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1297 PI3K-Akt signaling pathway 💬
 6件: FLT3, FLT4, KDR, KIT, PDGFRB, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1298 PI3K-Akt signaling pathway 💬
 2件: IFNAR1, IFNAR2 💬 D02745 💬 Interferon alfa-2b 2件: 25, 34 💬
1299 PI3K-Akt signaling pathway 💬
 1件: IL6 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1300 PI3K-Akt signaling pathway 💬
 1件: IL6 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1301 PI3K-Akt signaling pathway 💬
 2件: KDR, MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
1302 PI3K-Akt signaling pathway 💬
 2件: KIT, PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1303 PI3K-Akt signaling pathway 💬
 2件: KIT, PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1304 PI3K-Akt signaling pathway 💬
 3件: KIT, PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
1305 PI3K-Akt signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1306 PI3K-Akt signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1307 PI3K-Akt signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1308 PI3K-Akt signaling pathway 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1309 PI3K-Akt signaling pathway 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
1310 PI3K-Akt signaling pathway 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1311 PI3K-Akt signaling pathway 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
1312 PI3K-Akt signaling pathway 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
1313 Platelet activation 💬
 1件: PTGS1 💬 D00217 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271, 300, 337 💬
1314 Platelet activation 💬
 1件: PTGS1 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
1315 Platelet activation 💬
 1件: PTGS1 💬 D00903 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1316 Platelet activation 💬
 1件: PTGS1 💬 D00904 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1317 Platelet activation 💬
 1件: PTGS1 💬 D07816 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1318 Platinum drug resistance 💬
 1件: ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
1319 Platinum drug resistance 💬
 1件: ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
1320 Platinum drug resistance 💬
 2件: TOP2A, TOP2B 💬 D03899 💬 Doxorubicin 5件: 26, 28, 34, 65, 331 💬
1321 Platinum drug resistance 💬
 2件: TOP2A, TOP2B 💬 D00125 💬 Etoposide 11件: 11, 13, 14, 26, 28, 34, 60, 65, 85, 164, 331 💬
1322 Platinum drug resistance 💬
 2件: TOP2A, TOP2B 💬 D04107 💬 Etoposide 11件: 11, 13, 14, 26, 28, 34, 60, 65, 85, 164, 331 💬
1323 Prion disease 💬
 4件: IL1A, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1324 Prion disease 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1325 Prion disease 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1326 Prion disease 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D01068 💬 Vinblastine 2件: 34, 65 💬
1327 Prion disease 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08675 💬 Vinblastine 2件: 34, 65 💬
1328 Prion disease 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D02197 💬 Vincristine 4件: 26, 34, 65, 331 💬
1329 Prion disease 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08679 💬 Vincristine 4件: 26, 34, 65, 331 💬
1330 Progesterone-mediated oocyte maturation 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
1331 Progesterone-mediated oocyte maturation 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1332 Progesterone-mediated oocyte maturation 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1333 Progesterone-mediated oocyte maturation 💬
 1件: MAP2K1 💬 D10604 💬 Binimetinib 1件: 34 💬
1334 Progesterone-mediated oocyte maturation 💬
 1件: MAP2K1 💬 D09666 💬 Selumetinib 1件: 34 💬
1335 Progesterone-mediated oocyte maturation 💬
 1件: MAP2K1 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1336 Prolactin signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1337 Prolactin signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1338 Prolactin signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1339 Prolactin signaling pathway 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1340 Prolactin signaling pathway 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1341 Propanoate metabolism 💬
 1件: ABAT 💬 D00399 💬 Valproic acid 17件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 127, 222, 233, 256, 331 💬
1342 Prostate cancer 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
1343 Prostate cancer 💬
 3件: BRAF, PDGFRB, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1344 Prostate cancer 💬
 3件: BRAF, PDGFRB, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1345 Prostate cancer 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
1346 Prostate cancer 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
1347 Prostate cancer 💬
 2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
1348 Prostate cancer 💬
 2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
1349 Prostate cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1350 Prostate cancer 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1351 Prostate cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1352 Prostate cancer 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1353 Prostate cancer 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
1354 Prostate cancer 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1355 Prostate cancer 💬
 1件: PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1356 Prostate cancer 💬
 1件: PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1357 Prostate cancer 💬
 2件: PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
1358 Prostate cancer 💬
 2件: PDGFRA, PDGFRB 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
1359 Prostate cancer 💬
 2件: PDGFRA, PDGFRB 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
1360 Proteoglycans in cancer 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
1361 Proteoglycans in cancer 💬
 3件: BRAF, KDR, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1362 Proteoglycans in cancer 💬
 3件: BRAF, KDR, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1363 Proteoglycans in cancer 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
1364 Proteoglycans in cancer 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
1365 Proteoglycans in cancer 💬
 2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
1366 Proteoglycans in cancer 💬
 2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
1367 Proteoglycans in cancer 💬
 1件: KDR 💬 D03218 💬 Axitinib 1件: 34 💬
1368 Proteoglycans in cancer 💬
 1件: KDR 💬 D08881 💬 Cediranib 1件: 34 💬
1369 Proteoglycans in cancer 💬
 1件: KDR 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
1370 Proteoglycans in cancer 💬
 1件: KDR 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
1371 Proteoglycans in cancer 💬
 2件: KDR, MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
1372 Proteoglycans in cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1373 Proteoglycans in cancer 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1374 Proteoglycans in cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1375 Proteoglycans in cancer 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1376 Proteoglycans in cancer 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
1377 Proteoglycans in cancer 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1378 Proteoglycans in cancer 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1379 Proteoglycans in cancer 💬
 1件: TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1380 Proteoglycans in cancer 💬
 1件: TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1381 Proteoglycans in cancer 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
1382 Proteoglycans in cancer 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
1383 Rap1 signaling pathway 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
1384 Rap1 signaling pathway 💬
 6件: BRAF, FLT4, KDR, KIT, PDGFRB, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1385 Rap1 signaling pathway 💬
 6件: BRAF, FLT4, KDR, KIT, PDGFRB, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1386 Rap1 signaling pathway 💬
 7件: CSF1, FLT1, FLT4, KDR, KIT, PDGFRA, PDGFRB 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
1387 Rap1 signaling pathway 💬
 7件: CSF1, FLT1, FLT4, KDR, KIT, PDGFRA, PDGFRB 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
1388 Rap1 signaling pathway 💬
 2件: CSF1R, KIT 💬 D11270 💬 Pexidartinib 1件: 34 💬
1389 Rap1 signaling pathway 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
1390 Rap1 signaling pathway 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
1391 Rap1 signaling pathway 💬
 1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
1392 Rap1 signaling pathway 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
1393 Rap1 signaling pathway 💬
 3件: FLT1, FLT4, KDR 💬 D03218 💬 Axitinib 1件: 34 💬
1394 Rap1 signaling pathway 💬
 3件: FLT1, FLT4, KDR 💬 D08881 💬 Cediranib 1件: 34 💬
1395 Rap1 signaling pathway 💬
 2件: KDR, MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
1396 Rap1 signaling pathway 💬
 2件: KIT, PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1397 Rap1 signaling pathway 💬
 2件: KIT, PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1398 Rap1 signaling pathway 💬
 3件: KIT, PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
1399 Rap1 signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1400 Rap1 signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1401 Rap1 signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1402 Rap1 signaling pathway 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
1403 Rap1 signaling pathway 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
1404 Ras signaling pathway 💬
 3件: ABL1, KIT, PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1405 Ras signaling pathway 💬
 3件: ABL1, KIT, PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1406 Ras signaling pathway 💬
 4件: ABL1, KIT, PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
1407 Ras signaling pathway 💬
 8件: CSF1, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
1408 Ras signaling pathway 💬
 8件: CSF1, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
1409 Ras signaling pathway 💬
 3件: CSF1R, FLT3, KIT 💬 D11270 💬 Pexidartinib 1件: 34 💬
1410 Ras signaling pathway 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
1411 Ras signaling pathway 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
1412 Ras signaling pathway 💬
 1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
1413 Ras signaling pathway 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
1414 Ras signaling pathway 💬
 3件: FLT1, FLT4, KDR 💬 D03218 💬 Axitinib 1件: 34 💬
1415 Ras signaling pathway 💬
 3件: FLT1, FLT4, KDR 💬 D08881 💬 Cediranib 1件: 34 💬
1416 Ras signaling pathway 💬
 6件: FLT3, FLT4, KDR, KIT, PDGFRB, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1417 Ras signaling pathway 💬
 6件: FLT3, FLT4, KDR, KIT, PDGFRB, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1418 Ras signaling pathway 💬
 2件: KDR, MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
1419 Ras signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1420 Ras signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1421 Ras signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1422 Ras signaling pathway 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
1423 Ras signaling pathway 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
1424 Regulation of actin cytoskeleton 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
1425 Regulation of actin cytoskeleton 💬
 3件: BRAF, PDGFRB, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1426 Regulation of actin cytoskeleton 💬
 3件: BRAF, PDGFRB, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1427 Regulation of actin cytoskeleton 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
1428 Regulation of actin cytoskeleton 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
1429 Regulation of actin cytoskeleton 💬
 1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
1430 Regulation of actin cytoskeleton 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
1431 Regulation of actin cytoskeleton 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1432 Regulation of actin cytoskeleton 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1433 Regulation of actin cytoskeleton 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1434 Regulation of actin cytoskeleton 💬
 1件: PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1435 Regulation of actin cytoskeleton 💬
 1件: PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1436 Regulation of actin cytoskeleton 💬
 2件: PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
1437 Regulation of actin cytoskeleton 💬
 2件: PDGFRA, PDGFRB 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
1438 Regulation of actin cytoskeleton 💬
 2件: PDGFRA, PDGFRB 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
1439 Regulation of lipolysis in adipocytes 💬
 2件: PTGS1, PTGS2 💬 D00217 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271, 300, 337 💬
1440 Regulation of lipolysis in adipocytes 💬
 2件: PTGS1, PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
1441 Regulation of lipolysis in adipocytes 💬
 2件: PTGS1, PTGS2 💬 D00903 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1442 Regulation of lipolysis in adipocytes 💬
 2件: PTGS1, PTGS2 💬 D00904 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1443 Regulation of lipolysis in adipocytes 💬
 2件: PTGS1, PTGS2 💬 D07816 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1444 Regulation of lipolysis in adipocytes 💬
 1件: PTGS2 💬 D00567 💬 Celecoxib 10件:  2 ,  3 , 34, 46, 70, 89, 107, 161, 171, 271 💬
1445 Relaxin signaling pathway 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
1446 Relaxin signaling pathway 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
1447 Relaxin signaling pathway 💬
 1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
1448 Relaxin signaling pathway 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
1449 Relaxin signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1450 Relaxin signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1451 Relaxin signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1452 Relaxin signaling pathway 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1453 Relaxin signaling pathway 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1454 Relaxin signaling pathway 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
1455 Relaxin signaling pathway 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
1456 Renal cell carcinoma 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
1457 Renal cell carcinoma 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1458 Renal cell carcinoma 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1459 Renal cell carcinoma 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1460 Renal cell carcinoma 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1461 Renal cell carcinoma 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1462 Renal cell carcinoma 💬
 1件: MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
1463 Renal cell carcinoma 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
1464 Renal cell carcinoma 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
1465 Retrograde endocannabinoid signaling 💬
 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 D00549 💬 Propofol 10件:  6 , 21, 22, 34, 46, 70, 75, 84, 98, 296 💬
1466 Retrograde endocannabinoid signaling 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271, 300, 337 💬
1467 Retrograde endocannabinoid signaling 💬
 1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
1468 Retrograde endocannabinoid signaling 💬
 1件: PTGS2 💬 D00567 💬 Celecoxib 10件:  2 ,  3 , 34, 46, 70, 89, 107, 161, 171, 271 💬
1469 Retrograde endocannabinoid signaling 💬
 1件: PTGS2 💬 D00903 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1470 Retrograde endocannabinoid signaling 💬
 1件: PTGS2 💬 D00904 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1471 Retrograde endocannabinoid signaling 💬
 1件: PTGS2 💬 D07816 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1472 Rheumatoid arthritis 💬
 5件: CCL2, IL1A, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1473 Rheumatoid arthritis 💬
 2件: CSF1, FLT1 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
1474 Rheumatoid arthritis 💬
 2件: CSF1, FLT1 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
1475 Rheumatoid arthritis 💬
 1件: FLT1 💬 D03218 💬 Axitinib 1件: 34 💬
1476 Rheumatoid arthritis 💬
 1件: FLT1 💬 D08881 💬 Cediranib 1件: 34 💬
1477 Rheumatoid arthritis 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1478 Rheumatoid arthritis 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1479 Rheumatoid arthritis 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
1480 Rheumatoid arthritis 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
1481 RIG-I-like receptor signaling pathway 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1482 RIG-I-like receptor signaling pathway 💬
 1件: TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1483 RIG-I-like receptor signaling pathway 💬
 1件: TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1484 Salmonella infection 💬
 3件: IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1485 Salmonella infection 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1486 Salmonella infection 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1487 Salmonella infection 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1488 Salmonella infection 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1489 Salmonella infection 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1490 Salmonella infection 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1491 Salmonella infection 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1492 Salmonella infection 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D01068 💬 Vinblastine 2件: 34, 65 💬
1493 Salmonella infection 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08675 💬 Vinblastine 2件: 34, 65 💬
1494 Salmonella infection 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D02197 💬 Vincristine 4件: 26, 34, 65, 331 💬
1495 Salmonella infection 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08679 💬 Vincristine 4件: 26, 34, 65, 331 💬
1496 Serotonergic synapse 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
1497 Serotonergic synapse 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1498 Serotonergic synapse 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1499 Serotonergic synapse 💬
 3件: GABRB1, GABRB2, GABRB3 💬 D00549 💬 Propofol 10件:  6 , 21, 22, 34, 46, 70, 75, 84, 98, 296 💬
1500 Serotonergic synapse 💬
 1件: MAP2K1 💬 D10604 💬 Binimetinib 1件: 34 💬
1501 Serotonergic synapse 💬
 1件: MAP2K1 💬 D09666 💬 Selumetinib 1件: 34 💬
1502 Serotonergic synapse 💬
 1件: MAP2K1 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1503 Serotonergic synapse 💬
 2件: PTGS1, PTGS2 💬 D00217 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271, 300, 337 💬
1504 Serotonergic synapse 💬
 2件: PTGS1, PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
1505 Serotonergic synapse 💬
 2件: PTGS1, PTGS2 💬 D00903 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1506 Serotonergic synapse 💬
 2件: PTGS1, PTGS2 💬 D00904 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1507 Serotonergic synapse 💬
 2件: PTGS1, PTGS2 💬 D07816 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1508 Serotonergic synapse 💬
 1件: PTGS2 💬 D00567 💬 Celecoxib 10件:  2 ,  3 , 34, 46, 70, 89, 107, 161, 171, 271 💬
1509 Shigellosis 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
1510 Shigellosis 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
1511 Shigellosis 💬
 1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
1512 Shigellosis 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
1513 Shigellosis 💬
 2件: IL1B, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1514 Shigellosis 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1515 Shigellosis 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
1516 Shigellosis 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1517 Shigellosis 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1518 Shigellosis 💬
 1件: TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1519 Signaling pathways regulating pluripotency of stem cells 💬
 1件: BMPR2 💬 D03779 💬 Dibotermin alfa 1件: 34 💬
1520 Signaling pathways regulating pluripotency of stem cells 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1521 Signaling pathways regulating pluripotency of stem cells 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1522 Signaling pathways regulating pluripotency of stem cells 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1523 Signaling pathways regulating pluripotency of stem cells 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1524 Signaling pathways regulating pluripotency of stem cells 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1525 Small cell lung cancer 💬
 2件: CDK4, CDK6 💬 D10688 💬 Abemaciclib 1件: 34 💬
1526 Small cell lung cancer 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271, 300, 337 💬
1527 Small cell lung cancer 💬
 1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
1528 Small cell lung cancer 💬
 1件: PTGS2 💬 D00567 💬 Celecoxib 10件:  2 ,  3 , 34, 46, 70, 89, 107, 161, 171, 271 💬
1529 Small cell lung cancer 💬
 1件: PTGS2 💬 D00903 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1530 Small cell lung cancer 💬
 1件: PTGS2 💬 D00904 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1531 Small cell lung cancer 💬
 1件: PTGS2 💬 D07816 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1532 Sphingolipid signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1533 Sphingolipid signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1534 Sphingolipid signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1535 Sphingolipid signaling pathway 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1536 Sphingolipid signaling pathway 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1537 Sphingolipid signaling pathway 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1538 Sphingolipid signaling pathway 💬
 1件: TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1539 Sphingolipid signaling pathway 💬
 1件: TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1540 Spinocerebellar ataxia 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1541 Spinocerebellar ataxia 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
1542 Spinocerebellar ataxia 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1543 Staphylococcus aureus infection 💬
 1件: IL10 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1544 Synaptic vesicle cycle 💬
 2件: SLC6A2, SLC6A3 💬 D01296 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
1545 Synaptic vesicle cycle 💬
 2件: SLC6A2, SLC6A3 💬 D04999 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
1546 Systemic lupus erythematosus 💬
 2件: IL10, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1547 Systemic lupus erythematosus 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1548 Systemic lupus erythematosus 💬
 1件: TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1549 T cell receptor signaling pathway 💬
 1件: CDK4 💬 D10688 💬 Abemaciclib 1件: 34 💬
1550 T cell receptor signaling pathway 💬
 2件: IL10, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1551 T cell receptor signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1552 T cell receptor signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1553 T cell receptor signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1554 T cell receptor signaling pathway 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1555 T cell receptor signaling pathway 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1556 T cell receptor signaling pathway 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1557 T cell receptor signaling pathway 💬
 1件: TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1558 Taste transduction 💬
 6件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6 💬 D00549 💬 Propofol 10件:  6 , 21, 22, 34, 46, 70, 75, 84, 98, 296 💬
1559 Taste transduction 💬
 3件: SCN2A, SCN3A, SCN9A 💬 D00354 💬 Lamotrigine 5件: 13, 34, 38, 114, 144 💬
1560 Taste transduction 💬
 3件: SCN2A, SCN3A, SCN9A 💬 D00358 💬 Lidocaine 13件:  6 , 13, 34, 46, 51, 70, 84, 86, 107, 168, 226, 231, 256 💬
1561 Taste transduction 💬
 3件: SCN2A, SCN3A, SCN9A 💬 D02086 💬 Lidocaine 13件:  6 , 13, 34, 46, 51, 70, 84, 86, 107, 168, 226, 231, 256 💬
1562 Taste transduction 💬
 3件: SCN2A, SCN3A, SCN9A 💬 D08127 💬 Lidocaine 13件:  6 , 13, 34, 46, 51, 70, 84, 86, 107, 168, 226, 231, 256 💬
1563 Taurine and hypotaurine metabolism 💬
 2件: GAD1, GAD2 💬 D00399 💬 Valproic acid 17件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 127, 222, 233, 256, 331 💬
1564 Terpenoid backbone biosynthesis 💬
 2件: FNTA, FNTB 💬 D03720 💬 Tipifarnib 1件: 34 💬
1565 Terpenoid backbone biosynthesis 💬
 1件: HMGCR 💬 D00359 💬 Lovastatin 11件:  6 , 34, 46, 79, 156, 160, 195, 206, 263, 280, 310 💬
1566 Terpenoid backbone biosynthesis 💬
 1件: HMGCR 💬 D00434 💬 Simvastatin 21件:  6 , 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬
1567 TGF-beta signaling pathway 💬
 1件: BMPR2 💬 D03779 💬 Dibotermin alfa 1件: 34 💬
1568 TGF-beta signaling pathway 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1569 TGF-beta signaling pathway 💬
 1件: TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1570 TGF-beta signaling pathway 💬
 1件: TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1571 Th17 cell differentiation 💬
 2件: IL1B, IL6 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1572 Th17 cell differentiation 💬
 1件: IL6 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1573 Th17 cell differentiation 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1574 Th17 cell differentiation 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
1575 Th17 cell differentiation 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1576 Thermogenesis 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1577 Thermogenesis 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
1578 Thermogenesis 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1579 Thyroid cancer 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
1580 Thyroid cancer 💬
 2件: BRAF, RET 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1581 Thyroid cancer 💬
 2件: BRAF, RET 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1582 Thyroid cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1583 Thyroid cancer 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1584 Thyroid cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1585 Thyroid cancer 💬
 1件: RET 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
1586 Thyroid cancer 💬
 1件: RET 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
1587 Thyroid hormone signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1588 Thyroid hormone signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1589 Thyroid hormone signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1590 Thyroid hormone signaling pathway 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1591 Thyroid hormone signaling pathway 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
1592 Thyroid hormone signaling pathway 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1593 Thyroid hormone signaling pathway 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1594 Thyroid hormone signaling pathway 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1595 Tight junction 💬
 1件: CDK4 💬 D10688 💬 Abemaciclib 1件: 34 💬
1596 Tight junction 💬
 1件: ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
1597 Tight junction 💬
 1件: ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
1598 TNF signaling pathway 💬
 4件: CCL2, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1599 TNF signaling pathway 💬
 1件: CSF1 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
1600 TNF signaling pathway 💬
 1件: CSF1 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
1601 TNF signaling pathway 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1602 TNF signaling pathway 💬
 1件: MAP2K1 💬 D10604 💬 Binimetinib 1件: 34 💬
1603 TNF signaling pathway 💬
 1件: MAP2K1 💬 D09666 💬 Selumetinib 1件: 34 💬
1604 TNF signaling pathway 💬
 1件: MAP2K1 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1605 TNF signaling pathway 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271, 300, 337 💬
1606 TNF signaling pathway 💬
 1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
1607 TNF signaling pathway 💬
 1件: PTGS2 💬 D00567 💬 Celecoxib 10件:  2 ,  3 , 34, 46, 70, 89, 107, 161, 171, 271 💬
1608 TNF signaling pathway 💬
 1件: PTGS2 💬 D00903 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1609 TNF signaling pathway 💬
 1件: PTGS2 💬 D00904 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1610 TNF signaling pathway 💬
 1件: PTGS2 💬 D07816 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1611 TNF signaling pathway 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1612 Toll-like receptor signaling pathway 💬
 2件: IFNAR1, IFNAR2 💬 D02745 💬 Interferon alfa-2b 2件: 25, 34 💬
1613 Toll-like receptor signaling pathway 💬
 3件: IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1614 Toll-like receptor signaling pathway 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1615 Toll-like receptor signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1616 Toll-like receptor signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1617 Toll-like receptor signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1618 Toll-like receptor signaling pathway 💬
 1件: TLR7 💬 D02500 💬 Imiquimod 2件: 34, 51 💬
1619 Toll-like receptor signaling pathway 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1620 Toxoplasmosis 💬
 2件: IL10, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1621 Toxoplasmosis 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1622 Toxoplasmosis 💬
 1件: TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1623 Transcriptional misregulation in cancer 💬
 2件: CSF1R, FLT3 💬 D11270 💬 Pexidartinib 1件: 34 💬
1624 Transcriptional misregulation in cancer 💬
 1件: FLT1 💬 D03218 💬 Axitinib 1件: 34 💬
1625 Transcriptional misregulation in cancer 💬
 1件: FLT1 💬 D08881 💬 Cediranib 1件: 34 💬
1626 Transcriptional misregulation in cancer 💬
 2件: FLT1, FLT3 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
1627 Transcriptional misregulation in cancer 💬
 2件: FLT1, FLT3 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
1628 Transcriptional misregulation in cancer 💬
 1件: FLT3 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1629 Transcriptional misregulation in cancer 💬
 1件: FLT3 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1630 Transcriptional misregulation in cancer 💬
 1件: IL6 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1631 Transcriptional misregulation in cancer 💬
 1件: IL6 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1632 Transcriptional misregulation in cancer 💬
 1件: MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
1633 Tuberculosis 💬
 5件: IL10, IL1A, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1634 Tuberculosis 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1635 Tuberculosis 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1636 Tuberculosis 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1637 Tuberculosis 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1638 Tuberculosis 💬
 1件: VDR 💬 D00188 💬 Cholecalciferol 25件:  6 , 13, 19, 20, 28, 34, 46, 49, 51, 53, 56, 60, 65, 75, 84, 85, 96, 97, 98, 162, 202, 228, 271, 298, 299 💬
1639 Type I diabetes mellitus 💬
 2件: GAD1, GAD2 💬 D00399 💬 Valproic acid 17件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 127, 222, 233, 256, 331 💬
1640 Type I diabetes mellitus 💬
 3件: IL1A, IL1B, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1641 Type I diabetes mellitus 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1642 Type I diabetes mellitus 💬
 1件: TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1643 Type II diabetes mellitus 💬
 1件: CACNA1G 💬 D00399 💬 Valproic acid 17件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 127, 222, 233, 256, 331 💬
1644 Type II diabetes mellitus 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1645 Type II diabetes mellitus 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
1646 Type II diabetes mellitus 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1647 Type II diabetes mellitus 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1648 Type II diabetes mellitus 💬
 1件: TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1649 Type II diabetes mellitus 💬
 1件: TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1650 Valine, leucine and isoleucine degradation 💬
 1件: ABAT 💬 D00399 💬 Valproic acid 17件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 127, 222, 233, 256, 331 💬
1651 Vascular smooth muscle contraction 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
1652 Vascular smooth muscle contraction 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1653 Vascular smooth muscle contraction 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1654 Vascular smooth muscle contraction 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1655 Vascular smooth muscle contraction 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1656 Vascular smooth muscle contraction 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1657 VEGF signaling pathway 💬
 1件: KDR 💬 D03218 💬 Axitinib 1件: 34 💬
1658 VEGF signaling pathway 💬
 1件: KDR 💬 D10062 💬 Cabozantinib 1件: 34 💬
1659 VEGF signaling pathway 💬
 1件: KDR 💬 D08881 💬 Cediranib 1件: 34 💬
1660 VEGF signaling pathway 💬
 1件: KDR 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
1661 VEGF signaling pathway 💬
 1件: KDR 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
1662 VEGF signaling pathway 💬
 2件: KDR, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1663 VEGF signaling pathway 💬
 2件: KDR, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1664 VEGF signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1665 VEGF signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1666 VEGF signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1667 VEGF signaling pathway 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271, 300, 337 💬
1668 VEGF signaling pathway 💬
 1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
1669 VEGF signaling pathway 💬
 1件: PTGS2 💬 D00567 💬 Celecoxib 10件:  2 ,  3 , 34, 46, 70, 89, 107, 161, 171, 271 💬
1670 VEGF signaling pathway 💬
 1件: PTGS2 💬 D00903 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1671 VEGF signaling pathway 💬
 1件: PTGS2 💬 D00904 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1672 VEGF signaling pathway 💬
 1件: PTGS2 💬 D07816 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
1673 VEGF signaling pathway 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
1674 VEGF signaling pathway 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
1675 Viral carcinogenesis 💬
 2件: CDK4, CDK6 💬 D10688 💬 Abemaciclib 1件: 34 💬
1676 Viral myocarditis 💬
 1件: ABL1 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1677 Viral myocarditis 💬
 1件: ABL1 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1678 Viral myocarditis 💬
 1件: ABL1 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
1679 Viral protein interaction with cytokine and cytokine receptor 💬
 4件: CCL2, IL10, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1680 Viral protein interaction with cytokine and cytokine receptor 💬
 1件: CSF1 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
1681 Viral protein interaction with cytokine and cytokine receptor 💬
 1件: CSF1 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
1682 Viral protein interaction with cytokine and cytokine receptor 💬
 1件: CSF1R 💬 D11270 💬 Pexidartinib 1件: 34 💬
1683 Viral protein interaction with cytokine and cytokine receptor 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1684 Viral protein interaction with cytokine and cytokine receptor 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1685 Yersinia infection 💬
 5件: CCL2, IL10, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1686 Yersinia infection 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1687 Yersinia infection 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1688 Yersinia infection 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1689 Yersinia infection 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1690 Yersinia infection 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬

先頭へ